0001157523-21-000581.txt : 20210504 0001157523-21-000581.hdr.sgml : 20210504 20210504162116 ACCESSION NUMBER: 0001157523-21-000581 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210428 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HERBALIFE NUTRITION LTD. CENTRAL INDEX KEY: 0001180262 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32381 FILM NUMBER: 21888791 BUSINESS ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 310 410 9600 MAIL ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: HERBALIFE LTD. DATE OF NAME CHANGE: 20041214 FORMER COMPANY: FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD DATE OF NAME CHANGE: 20020814 8-K 1 a52422763.htm HERBALIFE NUTRITION LTD. 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 

FORM 8-K

 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): April 28, 2021

 
Herbalife Nutrition Ltd.
(Exact Name of Registrant as Specified in Charter)
 
 
Cayman Islands
001-32381
98-0377871
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
   
P.O. Box 309GT, Ugland House,
South Church Street, Grand Cayman
Cayman Islands
KY1-1106
(Address of Principal Executive Offices)
(Zip Code)
 
Registrant’s telephone number, including area code: c/o (213) 745-0500
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Shares, par value $0.0005 per share
 HLF
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company  ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐


Item 2.02.  Results of Operations and Financial Condition.

On May 4, 2021, Herbalife Nutrition Ltd. (the “Company”) issued a press release announcing its financial results for its first fiscal quarter ended March 31, 2021. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information contained in this Item 2.02 and Exhibit 99.1 attached to this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 4, 2021, the Company announced the planned retirement of the Company’s Chief Operating Officer, David Pezzullo. Effective August 2, 2021, Mr. Pezzullo will step down as Chief Operating Officer of the Company and will assume a part-time position as Senior Operations Advisor.  Mark Schissel, currently the Company’s Executive Vice President, Worldwide Operations, was appointed to succeed Mr. Pezzullo as the Chief Operating Officer effective August 2, 2021.

Mr. Schissel, 53, has served as the Company’s Executive Vice President, Worldwide Operations since August 2017. From April 2010 to August 2017, Mr. Schissel served as the Company’s Chief Information Officer. Mr. Schissel joined the Company in May 2007 as Vice President, IS Enterprise Applications, a position he held until April 2010. In connection with his appointment, Mr. Schissel will have an annual salary of $530,000, and a target annual cash incentive equal to 70% of base salary, subject to actual performance. Mr. Schissel will continue to be eligible to participate in the Company’s long-term incentive plan, with the size, form, and timing of grants, if any, subject to the approval of the Board’s Compensation Committee.  In August 2021, Mr. Schissel will be entitled to an award of performance share units having a grant date fair value equal to $1,100,000, reduced by the grant date fair value of the equity incentive awards previously granted to Mr. Schissel in 2021 in the ordinary course. Additionally, effective on August 2, 2021, Mr. Schissel will participate in the Herbalife International of America, Inc. Executive Officer Severance Plan in accordance with the terms and conditions thereof. Mr. Schissel is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.


Item 5.07.  Submission of Matters to a Vote of Security Holders.

On April 28, 2021, the Company held its 2021 Annual General Meeting of Shareholders. The Company’s shareholders voted on the four proposals outlined in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on March 16, 2021, and cast their votes as described below.
 
Proposal 1:    Election of Directors.
 
Nine board nominees for director were elected by a majority of the votes cast to serve until the 2022 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified. The voting results are as follows:
 
 
  
For
    
Against
    
Abstain
   
Broker
Non-votes
  
John Agwunobi  
    
90,706,493
      
2,077,700
      
8,233,616
      
3,437,326
  
Richard H. Carmona  
    
91,970,321
      
987,998
      
8,059,490
      
3,437,326
  
Kevin M. Jones  
    
92,701,888
      
245,720
      
8,070,201
      
3,437,326
  
Sophie L’Hélias  
    
92,703,570
      
243,956
      
8,070,283
      
3,437,326
  
Alan LeFevre  
    
92,363,848
      
569,294
      
8,084,667
      
3,437,326
  
Juan Miguel Mendoza  
    
91,590,404
      
1,367,351
      
8,060,054
      
3,437,326
  
Donal Mulligan  
    
92,704,861
      
243,557
      
8,069,391
      
3,437,326
  
Maria Otero  
    
92,676,091
      
273,009
      
8,068,709
      
3,437,326
  
John Tartol  
    
91,572,112
      
1,387,143
      
8,058,554
      
3,437,326
  
 

Proposal 2:    Approve, on an advisory basis, the compensation of the Company’s named executive officers.
 
The advisory resolution to approve the compensation of the named executive officers was approved. The voting results are as follows:
 
For
  
Against
 
Abstain
  
Broker
Non-votes
86,072,512
  
5,982,664
  
8,962,633
  
3,437,326
 

Proposal 3:    Approve an amendment and restatement of the Company’s 2014 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan.
 
The amendment and restatement of the Company’s 2014 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan was approved. The voting results are as follows:
 
For
  
Against
 
Abstain
  
Broker
Non-votes
83,464,293
  
8,561,871
  
8,991,644
  
3,437,326
 

Proposal 4:    Ratify the appointment of the Company’s independent registered public accounting firm for fiscal year 2021.
 
The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2021 was ratified. The voting results are as follows:
 
For
  
Against
  
Abstain
  
Broker
Non-votes
95,019,777
  
523,110
  
8,912,248
  
0
 
 
Item 9.01.  Financial Statements and Exhibits.

(d)
Exhibits.

   
104
Cover Page Interactive Data File – The cover page from the Company’s Current Report on Form 8-K filed on May 4, 2021 is formatted in Inline XBRL (included as Exhibit 101).
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Herbalife Nutrition Ltd.
     
May 4, 2021
By:
/s/ HENRY C. WANG
 
 
Name:
Henry C. Wang
 
 
Title:
EVP, General Counsel and Corporate Secretary

EX-99.1 2 a52422763ex99_1.htm EXHIBIT 99.1
Exhibit 99.1


Herbalife Nutrition Raises Full Year 2021 Guidance;
Reports Record First Quarter Net Sales with Growth of 18.9% Versus Prior Year


LOS ANGELES, May 4th, 2021 – Herbalife Nutrition Ltd. (NYSE: HLF) today reported financial results for the first quarter ended March 31, 2021:
 
HIGHLIGHTS
 
▪
First quarter 2021 net sales of $1.5 billion, an 18.9% increase compared to the first quarter 2020.  Five of six geographic regions reported year-over-year net sales growth in the quarter.

▪
March worldwide net sales set a single-month, net sales record.

▪
First quarter 2021 reported diluted EPS of $1.33 and adjusted1 diluted EPS of $1.422, compared to $0.32 and $0.882, respectively, for the first quarter 2020.  First quarter 2021 adjusted earnings per share increased 61.4% compared to the first quarter 2020.

▪
Raising FY 2021 net sales guidance ranges to 9.0% to 15.0% growth, as well as raising FY 2021 reported and adjusted1 diluted EPS guidance ranges to $4.41 - $4.81 and $4.65 – $5.05, respectively.


MANAGEMENT COMMENTARY
 
The Company’s double-digit net sales growth of 18.9% in the first quarter is a reflection of the long-established strategy and growth trajectory that started in 2018. The demand for Herbalife Nutrition products, combined with the determination and entrepreneurial spirit of the Company’s independent distributors, resulted in first quarter net sales of $1.5 billion, which is a record for the Company.

 “This quarter we delivered record first quarter results with net sales growth of 18.9%, as our distributors delivered valuable nutrition solutions to consumers around the world,” said John Agwunobi, Chairman and CEO of Herbalife Nutrition.

The Company is seeing continued consumer interest in health and wellness products which is driving demand for its range of nutritional product offerings. The Company’s global products and direct sales channel allow its independent distributors to support consumers as they reach their nutrition goals.

The fundamentals of the business are strong, evidenced by year-over-year growth and the record first quarter. Five of the Company’s six regions experienced net sales growth with three of the six regions: North America, Asia Pacific and EMEA, growing by more than 20%. In particular, India set a new quarterly net sales record for the third quarter in a row, with year-over-year growth of 37%.  Additionally, the Company is seeing the first net sales benefit from currency since the fourth quarter 2017, as currency was a net sales tailwind of approximately 180 bps, excluding Venezuela.


1 Adjusted diluted EPS is a non-GAAP measure and excludes the impact of: non-cash interest expense and amortization associated with the Company’s convertible notes, expenses related to regulatory inquiries and legal accruals, debt issuance costs related to the senior secured credit facility amendment, and net expenses related to the COVID-19 pandemic. See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a detailed reconciliation of adjusted net income to net income calculated in accordance with GAAP and a reconciliation of adjusted diluted EPS to diluted EPS calculated in accordance with GAAP and a discussion of why we believe these non-GAAP measures are useful. See the “Outlook” discussion below and the related footnotes for additional information regarding adjusted diluted EPS guidance.
2 First quarter 2021 results were impacted by China grant income of approximately $15.9 million, or $0.11 per diluted share and expenses related to the China Growth and Impact Investment Program of approximately $3.5 million or $0.03 per diluted share. First quarter 2020 results were impacted by China grant income of approximately $9.1 million, or $0.05 per diluted share and expenses related to the China Growth and Impact Investment Program of approximately $2.2 million or $0.01 per diluted share. First quarter 2020 adjusted results have been updated in Schedule A to no longer exclude China grant income.

Agwunobi added, “Due to the ongoing performance of our materially enlarged sales force and the increased awareness and consumer demand for our rapidly expanding product portfolio, we have meaningfully raised and narrowed our full year 2021 guidance.  We believe in the long-term growth opportunity of our business.”

Based on the continued increased growth in net sales, the Company’s new guidance calls for net sales growth to be in a range of 9% to 15%, up from its prior range of 6% to 14%.  Additionally, the midpoint of our reported and adjusted1 diluted EPS guidance range increased by approximately 7%.

The demand for the Company’s full line of nutrition products and adaption of technology tools provided by the Company to its independent distributors contributed to double-digit growth in over 50 of the Company’s markets.  The Company’s sports nutrition line continues to drive growth, with worldwide net sales in energy, sports, and fitness category increasing approximately 34% during the first quarter.  Furthermore, the Company’s targeted nutrition category, which includes health and wellness products, grew by 21% while the core weight management product category grew by 16% in the quarter.  Moreover, consumer facing technology used by the Company’s independent distributors to interact with their customers, particularly in cases where face-to-face interactions are unable to take place, was also a key factor in helping drive growth.

We are deeply grateful to our employees and distributors around the world who continue to deliver on our promise to customers every day, despite the ongoing pandemic.

To drive shareholder value, during the first quarter the Company executed an approximately $621 million in share repurchases. The Company has just under $1.5 billion remaining on our three-year $1.5 billion share repurchase authorization.

“We repurchased $621 million in shares in the first quarter. We will continue to keep a sharp focus on enhancing shareholder value and capital allocation as we look to deploy excess cash to the almost $1.5 billion remaining on our share repurchase program.” said Alex Amezquita, Chief Financial Officer, Herbalife Nutrition.

The company will host a virtual Investor Day in August 2021.

2
 
First Quarter 2021 Key Metrics
 
Regional Net Sales and Foreign Exchange (“FX”) Impact


Region
Reported Net
Sales
1Q’21 (mil)
Growth/Decline
including FX
vs. 1Q’20
Growth/Decline
excluding FX
vs. 1Q’20 (a)
Asia Pacific
 $        403.4
22.4%
19.9%
North America
 $        360.5
29.8%
29.6%
EMEA
 $        354.2
36.9%
32.1%
China
 $        169.3
(10.8%)
(17.1%)
Mexico
 $        118.2
2.9%
5.4%
South & Central America (b)
 $          96.0
4.9%
*
Worldwide Total
 $     1,501.6
18.9%
*
South & Central America excl. Venezuela (b)
$         95.6
4.9%
12.7%
Worldwide Total excl Venezuela (b)
 $     1,501.2
19.0%
17.1%

(a) Growth/decline in net sales excluding the effects of foreign exchange is based on “net sales in local currency,” a non-GAAP financial measure. See the Company’s Form 10-Q for the three months ended March 31, 2021 for a discussion of why we believe adjusting for the effects of foreign exchange is useful.
(b) Venezuela has been generally impacted by significant price increases and erosion in foreign currency exchange rates. Venezuela represents less than 1% of the Company’s consolidated net sales.  See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a discussion of why we believe adjusting for Venezuela is useful.
* Figure not meaningful due to significant foreign currency fluctuations in Venezuela and the price increases implemented as a result thereof that, when considered in isolation, have a disproportionately large impact on the Company’s South and Central American region and consolidated results. Amounts were 23.0% and 17.8% for South & Central America and Worldwide Total, respectively.


Regional Volume Point Metrics

 
Volume Points
Region
1Q’21 (mil)
Yr/Yr % Chg
Asia Pacific
490.1
19.6%
North America
465.8
30.8%
EMEA
424.5
26.1%
China
100.8
(19.1%)
Mexico
217.8
3.8%
South and Central America
128.8
1.7%
Worldwide Total
1,827.8
16.9%


3

Outlook
 
Following is the Company’s second quarter and updated full year 2021 guidance based on current business trends:

 
Three Months Ending
Twelve Months Ending
 
June 30, 2021
December 31, 2021
 
Low
High
Low
High
Volume Point Growth vs 2020
6.5%
12.5%
4.5%
10.5%
Net Sales Growth vs 2020 (a)
13.5%
19.5%
9.0%
15.0%
Diluted EPS (a) (b)
$1.17
$1.32
$4.41
$4.81
Adjusted Diluted EPS (a) (b) (c)
$1.22
$1.37
$4.65
$5.05
Cap Ex ($ millions)
$40.0
$55.0
$175.0
$225.0
Effective Tax Rate (a) (b)
20.3%
26.3%
19.4%
25.4%
Adjusted Effective Tax Rate (a) (b) (c)
19.5%
25.5%
18.7%
24.7%
Net Sales Growth vs. 2020 (Currency Adjusted) (a) (d)
9.0%
15.0%
7.0%
13.0%
Adjusted Diluted EPS (Currency Adjusted) (a) (b) (c) (d)
$1.03
$1.18
$4.53
$4.93

 
(a) Excludes any future potential Venezuela currency devaluations and associated pricing and inflationary consequences.
 
(b) Excludes the following items that cannot be accurately predicted: any future potential ongoing tax effects from the exercise or vesting of equity awards that could impact the Company's tax rate due to the stock compensation accounting standard, benefits from future potential China grant income, any future potential dilution from the Company’s convertible notes due in 2024, as well as any future impact of the China Growth and Impact Investment Program.
 
(c) Adjusted diluted EPS and adjusted effective tax rate excludes the impact of non-cash interest expense and amortization associated with the Company’s convertible notes, as detailed in Schedule A. See Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a detailed reconciliation of adjusted diluted EPS to diluted EPS calculated in accordance with GAAP and a discussion of why the Company believes these non-GAAP measures are useful.
 
(d) Currency adjusted net sales and adjusted diluted EPS represent projections translated into US dollars at currency rates equal to the average rates used to translate 2020 second quarter and full year net sales and diluted EPS and adjusted for items such as hedging gains/losses and Venezuela to be directly comparable to 2020 values. See our Company’s Form 10-Q for the three months ended March 31, 2021 and Schedule A – “Reconciliation of Non-GAAP Financial Measures” for a discussion of why we believe adjusting for the effects of foreign exchange is useful.


▪
With respect to guidance, the Company cannot accurately predict the impact to its share base from any future share repurchases. Accordingly, any impact thereof is excluded from the guidance table above.

▪
Guidance is based on the average daily exchange rates for the first two weeks of April 2021. 

▪
Adjusted(a)(b)(c) diluted EPS guidance for the second quarter 2021 includes a projected currency tailwind of approximately $0.19 per diluted share versus the second quarter 2020.

▪
Full year 2021 adjusted(a)(b)(c) diluted EPS guidance includes a projected currency tailwind of approximately $0.12 per diluted share versus the full year 2020. This $0.12 tailwind is $0.23 unfavorable as compared to the expected $0.35 tailwind included in the full year 2021 guidance provided on February 17, 2021.

4
 
Earnings Conference Call

Herbalife Nutrition senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Tuesday, May 4th, 2021, at 2:30 p.m. PT (5:30 p.m. ET).

The dial-in number for this conference call for domestic callers is (833) 962-1459, and (956) 394-3596 for international callers (conference ID: 3526984). Live audio of the conference call will be simultaneously webcast in the investor relations section of the Company's website at http://ir.Herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID: 3526984). The webcast of the teleconference will be archived and available on Herbalife Nutrition's website.


About Herbalife Nutrition Ltd.
 
Herbalife Nutrition is a global company that has been changing people's lives with great nutrition products and a proven business opportunity for its independent distributors since 1980. The Company offers high-quality, science-backed products, sold in over 90 markets by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. Through the Company’s global campaign to eradicate hunger, Herbalife Nutrition is also committed to bringing nutrition and education to communities around the world.

For more information, please visit IAmHerbalifeNutrition.com.

Herbalife Nutrition also encourages investors to visit its investor relations website at ir.herbalife.com as financial and other information is updated and new information is posted.

Media Contact:                                                                                                  
Jennifer Butler                                                                                                  
VP, Media Relations                                                                                                                
213.745.0420

Investor Contact:
Eric Monroe
Senior Director, Investor Relations
213.745.0449

5

Forward-Looking Statements
 
This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by the COVID-19 pandemic. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include the following:
 

 •
the potential impacts of the COVID-19 pandemic on us; our Members, customers, and supply chain; and the world economy;
 

 •
our ability to attract and retain Members;
 

 •
our relationship with, and our ability to influence the actions of, our Members;
 

 •
our noncompliance with, or improper action by our employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations;
 

 •
adverse publicity associated with our Company or the direct-selling industry, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;
 

 •
changing consumer preferences and demands;
 

 •
the competitive nature of our business and industry;
 

 •
legal and regulatory matters, including regulatory actions concerning, or legal challenges to, our products or network marketing program and product liability claims;
 

 •
the Consent Order entered into with the FTC, the effects thereof and any failure to comply therewith;
 

 •
risks associated with operating internationally and in China;
 

 •
our dependence on increased penetration of existing markets;
 

 •
any material disruption to our business caused by natural disasters, other catastrophic events, acts of war or terrorism, cybersecurity incidents, pandemics and/or other acts by third parties;
 

 •
noncompliance by us or our Members with any privacy laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information;
 

 •
contractual limitations on our ability to expand or change our direct-selling business model;
 

 •
our reliance on our information technology infrastructure and manufacturing facilities and those of our outside manufacturers;
 

 •
the sufficiency of our trademarks and other intellectual property;
 

 •
product concentration;
 

 •
our reliance upon, or the loss or departure of any member of, our senior management team;
 

 •
restrictions imposed by covenants in the agreements governing our indebtedness;
 
6


 •
risks related to our convertible notes;
 

 •
changes in, and uncertainties relating to, the application of transfer pricing, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation;
 

 •
our incorporation under the laws of the Cayman Islands; and
 

 •
share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.
 
We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.


7
 
Results of Operations
 
Herbalife Nutrition Ltd. and Subsidiaries
Condensed Consolidated Statements of Income
(In millions, except per share amounts)

   
Three Months Ended
  
   
3/31/2021
    
3/31/2020
  
   
(unaudited)
  
North America
  
$
360.5
    
$
277.7
  
EMEA
    
354.2
      
258.7
  
Asia Pacific
    
403.4
      
329.7
  
Mexico
    
118.2
      
114.9
  
China
    
169.3
      
189.9
  
South and Central America
    
96.0
      
91.5
  
Worldwide Net Sales
    
1,501.6
      
1,262.4
  
Cost of Sales
    
314.3
      
245.7
  
  Gross Profit
    
1,187.3
      
1,016.7
  
Royalty Overrides
    
474.0
      
381.2
  
Selling, General, and Administrative Expenses
    
506.7
      
549.0
  
Other Operating Income (1)
    
(15.9
)
    
(9.1
)
  Operating Income
    
222.5
      
95.6
  
Interest Expense, net
    
37.5
      
25.0
  
Income Before Income Taxes
    
185.0
      
70.6
  
Income Taxes
    
37.6
      
25.0
  
Net Income
  
$
147.4
    
$
45.6
  
                 
Weighted-Average Shares Outstanding:
                
Basic
    
108.4
      
137.8
  
Diluted
    
111.1
      
140.2
  
                 
Earnings Per Share:
                
Basic
  
$
1.36
    
$
0.33
  
Diluted
  
$
1.33
    
$
0.32
  

(1) Other Operating Income for the three months ended March 31, 2021 and March 31, 2020 relates to certain China government grant income.

8

Herbalife Nutrition Ltd. and Subsidiaries
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)

   
Mar 31,
    
Dec 31,
  
   
2021
    
2020
  
             
ASSETS
            
Current Assets:
            
Cash and cash equivalents
  
$
611.7
    
$
1,045.4
  
Receivables, net
    
101.3
      
83.3
  
Inventories
    
509.4
      
501.4
  
Prepaid expenses and other current assets
    
164.5
      
145.7
  
Total Current Assets
    
1,386.9
      
1,775.8
  
                 
Property, plant and equipment, net
    
389.8
      
390.2
  
Operating lease right-of-use assets
    
224.9
      
222.8
  
Marketing-related intangibles and other intangible assets, net
    
313.2
      
313.3
  
Goodwill
    
97.2
      
100.5
  
Other assets
    
254.8
      
273.5
  
Total Assets
  
$
2,666.8
    
$
3,076.1
  
                 
                 
LIABILITIES AND SHAREHOLDERS' DEFICIT
                
Current Liabilities:
                
Accounts payable
  
$
111.2
    
$
88.7
  
Royalty overrides
    
342.7
      
358.2
  
Current portion of long-term debt
    
24.7
      
22.9
  
Other current liabilities
    
588.6
      
657.5
  
Total Current Liabilities
    
1,067.2
      
1,127.3
  
                 
Non-current liabilities:
                
Long-term debt, net of current portion
    
2,556.3
      
2,405.5
  
Non-current operating lease liabilities
    
207.5
      
206.7
  
Other non-current liabilities
    
198.1
      
192.7
  
Total Liabilities
    
4,029.1
      
3,932.2
  
                 
Commitments and Contingencies
                
                 
Shareholders' deficit:
                
Common shares
    
0.1
      
0.1
  
Paid-in capital in excess of par value
    
298.7
      
342.3
  
Accumulated other comprehensive loss
    
(205.0
)
    
(182.2
)
Accumulated deficit
    
(1,127.2
)
    
(687.4
)
Treasury stock
    
(328.9
)
    
(328.9
)
Total Shareholders' Deficit
    
(1,362.3
)
    
(856.1
)
                 
Total Liabilities and Shareholders' Deficit
  
$
2,666.8
    
$
3,076.1
  

9

Herbalife Nutrition Ltd. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(In millions)
(Unaudited)

   
Three Months Ended
  
   
3/31/2021
    
3/31/2020
  
CASH FLOWS FROM OPERATING ACTIVITIES:
            
Net income
  
$
147.4
    
$
45.6
  
Adjustments to reconcile net income to net cash provided by
                
operating activities:
                
Depreciation and amortization
    
26.4
      
24.2
  
Share-based compensation expenses
    
13.3
      
10.3
  
Non-cash interest expense
    
7.1
      
6.3
  
Deferred income taxes
    
8.3
      
7.4
  
Inventory write-downs
    
9.5
      
3.6
  
Foreign exchange transaction loss
    
0.3
      
8.5
  
Other
    
(1.1
)
    
(5.0
)
Changes in operating assets and liabilities:
                
Receivables
    
(21.9
)
    
(7.8
)
Inventories
    
(31.5
)
    
(7.4
)
Prepaid expenses and other current assets
    
(15.7
)
    
(18.1
)
Accounts payable
    
23.4
      
2.9
  
Royalty overrides
    
(8.4
)
    
(22.9
)
Other current liabilities
    
(52.0
)
    
92.9
  
Other
    
5.0
      
1.2
  
NET CASH PROVIDED BY OPERATING ACTIVITIES
    
110.1
      
141.7
  
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
                
Purchases of property, plant and equipment
    
(33.4
)
    
(24.4
)
Other
    
-
      
0.1
  
NET CASH USED IN INVESTING ACTIVITIES
    
(33.4
)
    
(24.3
)
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
                
Borrowings from senior secured credit facility, net of discount
    
270.0
      
30.2
  
Principal payments on senior secured credit facility and other debt
    
(125.2
)
    
(5.3
)
Share repurchases
    
(645.0
)
    
(4.7
)
Other
    
1.0
      
0.8
  
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES
    
(499.2
)
    
21.0
  
                 
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
    
(11.2
)
    
(33.8
)
NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
    
(433.7
)
    
104.6
  
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF PERIOD
    
1,054.0
      
847.5
  
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD
  
$
620.3
    
$
952.1
  

10

Supplemental Information

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

(Unaudited and unreviewed), (All tables provide Dollars in millions, except per Share Data)

Adjusted Net Income and Adjusted Diluted EPS

In addition to its reported results and guidance calculated in accordance with GAAP, the Company has included in this release adjusted net income and adjusted diluted EPS, performance measures that the Securities and Exchange Commission defines as “non-GAAP financial measures.”  Management believes that such non-GAAP financial measures, when read in conjunction with the Company’s reported or forecasted results, in each case calculated in accordance with GAAP, can provide useful supplemental information for investors because they facilitate a period to period comparative assessment of the Company’s operating performance relative to its performance based on reported or forecasted results under GAAP, while isolating the effects of some items that vary from period to period without any correlation to core operating performance and eliminate certain charges that management believes do not reflect the Company’s operations and underlying operational performance.  The Company’s definition of adjusted net income and adjusted diluted earnings per share may not be comparable to similarly titled measures used by other companies because other companies may not calculate them in the same manner as the Company does and should not be viewed in isolation from nor as alternatives to net income or diluted EPS calculated in accordance with GAAP.

Venezuela Adjustments

The impact of foreign currency fluctuations in Venezuela and the price increases the Company implements as a result of the highly inflationary economy in that market can each, when considered in isolation, have a disproportionately large impact to the Company’s consolidated results despite the offsetting nature of these drivers and that net sales in Venezuela, which represent less than 1% of the Company’s consolidated net sales, are not material to our consolidated results. Therefore, in certain instances, the Company believes it is helpful to provide additional information with respect to these factors as reported and excluding the impact of Venezuela to illustrate the disproportionate nature of Venezuela’s individual pricing and foreign exchange impact to the Company’s consolidated results. However, excluding the impact of Venezuela from these measures is not in accordance with U.S. GAAP and should not be considered in isolation or as an alternative to the presentation and discussion thereof calculated in accordance with U.S. GAAP.

China grant income is no longer excluded from the Company’s adjusted results and prior period information has been updated to reflect the current period presentation.

11

The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:

   
Three Months Ended
  
   
3/31/2021
    
3/31/2020
  
   
(in millions)
  
             
Net income, as reported
  
$
147.4
    
$
45.6
  
Expenses related to regulatory inquiries and legal accruals (1) (2) (3)
    
-
      
84.5
  
Non-cash interest expense and amortization of non-cash issuance costs (1) (2) (4)
    
5.7
      
5.2
  
Debt issuance costs related to the senior secured credit facility amendment (1) (2) (5)
    
1.1
      
0.5
  
Net expenses related to COVID-19 pandemic (1) (2)
    
4.8
      
5.8
  
Income tax adjustments for above items (1) (2)
    
(1.2
)
    
(18.4
)
Net income, as adjusted
  
$
157.8
    
$
123.2
  


The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items.

   
Three Months Ended
  
   
3/31/2021
    
3/31/2020
  
   
(per share)
  
             
Diluted earnings per share, as reported
  
$
1.33
    
$
0.32
  
Expenses related to regulatory inquiries and legal accruals (1) (2) (3)
    
-
      
0.60
  
Non-cash interest expense and amortization of non-cash issuance costs (1) (2) (4)
    
0.05
      
0.04
  
Debt issuance costs related to the senior secured credit facility amendment (1) (2) (5)
    
0.01
      
-
  
Net expenses related to COVID-19 pandemic (1) (2)
    
0.04
      
0.04
  
Income tax adjustments for above items (1) (2)
    
(0.01
)
    
(0.13
)
Adjusted diluted earnings per adjusted share (6)
  
$
1.42
    
$
0.88
  

(1) Based on interim income tax reporting rules, these expenses are not considered discrete items. As a result, the Company's full year effective tax rate is impacted by these items. When applying the full year effective tax rate to year-to-date income, the Company's year-to-date tax provision recorded with respect to these non-GAAP adjustments is different from the forecasted full-year tax provision impact of these items. As a consequence, adjustments to the year-to-date and quarterly tax impacts will be recorded as the adjusted full year effective tax rate is applied to income in subsequent periods. Additionally, adjustments to items unrelated to these non-GAAP adjustments may have an effect on the income tax impact of these non-GAAP adjustments in subsequent periods. The Company plans to update the income tax impact of these items in subsequent interim reporting periods.

12

(2) Excludes tax (benefit)/expense as follows:

   
Three Months Ended
  
   
3/31/2021
    
3/31/2020
  
   
(in millions)
  
             
Expenses related to regulatory inquiries and legal accruals
    
-
    
$
(17.1
)
Non-cash interest expense and amortization of non-cash issuance costs
    
0.1
      
0.1
  
Debt issuance costs related to the senior secured credit facility amendment
    
(0.2
)
    
(0.1
)
Net expenses related to COVID-19 pandemic
    
(1.1
)
    
(1.3
)
Total income tax adjustments
  
$
(1.2
)
  
$
(18.4
)
                 
                 
   
Three Months Ended
  
   
3/31/2021
    
3/31/2020
  
   
(per share)
  
                 
Expenses related to regulatory inquiries and legal accruals
    
-
      
(0.12
)
Non-cash interest expense and amortization of non-cash issuance costs
    
-
      
-
  
Debt issuance costs related to the senior secured credit facility amendment
    
-
      
-
  
Net expenses related to COVID-19 pandemic
    
(0.01
)
    
(0.01
)
Total income tax adjustments
  
$
(0.01
)
  
$
(0.13
)

(3) Includes legal accrual recorded during the three months ended March 31, 2020 of $83.0 million relating to the SEC and DOJ investigations on the FCPA matter in China as described in the Company's Form 10-Q for the three months ended March 31, 2021.
(4) Relates to non-cash expense on the Company's 2.625% convertible senior notes due 2024.
(5) The 2021 amount relates to costs incurred in the amendment of the senior secured credit facility, which, among other things, reduced the interest rate for borrowings under the Term Loan B. The 2020 amount relates to costs incurred in the amendment of the senior secured credit facility which, among other things, extended the maturity, increased borrowings and reduced interest rate of both Term Loan A and 2018 Revolving Credit Facility. There is no per share amount for 2020 due to rounding.
(6) Amounts may not total due to rounding

The following is a reconciliation of diluted earnings per share guidance, presented in accordance with U.S. generally accepted accounting principles, to adjusted diluted earnings per share guidance for certain items.

 
Three Months Ending
  
Twelve Months Ending
 
June 30, 2021
  
December 31, 2021
       
Diluted EPS Guidance
 $1.17 - $1.32
  
 $4.41 - $4.81
Non-cash interest expense and amortization of non-cash issuance costs (1)
0.05
  
0.20
Net expenses related to Covid-19 pandemic (2)
0.00
  
0.04
Debt issuance costs related to the senior secured credit facility amendment (3)
0.00
  
0.01
Income tax adjustments for above items (4)
(0.00)
  
(0.01)
Adjusted diluted EPS guidance
$1.22 - $1.37
  
$4.65 - $5.05

(1) Relates to non-cash expense on our convertible notes.
(2) Excludes tax impact of $1.1 million for the twelve months ending December 31, 2021.
(3) Relates to costs incurred in the amendment of the Term Loan B.  Excludes tax impact of $0.2 million for the twelve months ending December 31, 2021.
(4) Aggregates the individual tax impacts of each item as described in greater detail in footnotes 2 and 3 above.


13
 EX-101.SCH 3 hlf-20210428.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 hlf-20210428_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Amendment Flag City Area Code Entity Address, City or Town Entity Address, Country Document Period End Date Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Local Phone Number Entity Address, Postal Zip Code Entity Address, State or Province Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Document Fiscal Year Focus Document Fiscal Period Focus Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity File Number Entity Emerging Growth Company EX-101.PRE 5 hlf-20210428_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 logo.jpg begin 644 logo.jpg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end XML 7 a52422763_htm.xml IDEA: XBRL DOCUMENT 0001180262 2021-04-28 2021-04-28 false 0001180262 8-K 2021-04-28 Herbalife Nutrition Ltd. E9 001-32381 98-0377871 P.O. Box 309GT, Ugland House South Church Street Grand Cayman KY KY1-1106 213 745-0500 Not Applicable false false false false Common Shares HLF NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document and Entity Information
Apr. 28, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 28, 2021
Entity Registrant Name Herbalife Nutrition Ltd.
Entity Incorporation, State or Country Code E9
Entity File Number 001-32381
Entity Tax Identification Number 98-0377871
Entity Address, Address Line One P.O. Box 309GT, Ugland House
Entity Address, Address Line Two South Church Street
Entity Address, City or Town Grand Cayman
Entity Address, Country KY
Entity Address, Postal Zip Code KY1-1106
City Area Code 213
Local Phone Number 745-0500
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001180262
Title of 12(b) Security Common Shares
Trading Symbol HLF
Security Exchange Name NYSE
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 95 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://herbalife.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52422763.htm a52422763ex99_1.htm hlf-20210428.xsd hlf-20210428_lab.xml hlf-20210428_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52422763.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "a52422763.htm" ] }, "labelLink": { "local": [ "hlf-20210428_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hlf-20210428_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hlf-20210428.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hlf", "nsuri": "http://herbalife.com/20210428", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a52422763.htm", "contextRef": "c20210428to20210428", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://herbalife.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a52422763.htm", "contextRef": "c20210428to20210428", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://herbalife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001157523-21-000581-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-21-000581-xbrl.zip M4$L#!!0 ( *:"I%(VB?EB5B )0P 0 - 834R-#(R-S8S+FAT;>U= M;5/C.+;^?JOV/^AF=F;I*B?X_05HJFB:[F:FFZ: V9F]7[9D24X\[=@9V08R MO_X>R7;B! <")'3"F-J=3F)9.CKOSY%D'PRR881NAU&<[MWZ/ K?=@99-MK; MW;VYN>F)7WH)[^_JJFKLAG&:X9BP3MD^"N-O]S07EWV<3IK?WFE_8\C6FN=Y MN_+JI&D:-C6$;K7=W[]\OB0#-L3=>7K$\'1Z8YT:>[>X6#4-T\34->>^R18M M)C?<+FJK"<8 \>SW=Q>?I\VSYO;3IKL9QW$:)'R(LS")14]65]6[NEWKI)LR M,M,1?._UD^L'^W&[AE;UDZ?=/L:C23\!3GU)3'E!W.)U5:UV"V5S?*S&A0L- MS?.,+V2EMPM7JX9Q/FQN2#.^FXU';!=:,!Z2R0U)O,0]2=R=NX\D>9SQP.[)8/F&\25ACFD/+NK(_!C0]-!%$R:#ACW<10&K$>2(;35-=74W;+E M8GL7CJ=S^(__0>A@P#"5G^!S%F81.SS8+?XM?_S?;A=]#@F+4T91ENRA=WD* MZI^FZ+>0LZ*1_'N?$-"#.$.$,YQ!8]&NCT[>?SRZ"$(PF7Z*SB^^PD>&G)[9 M4WMJ[>[C9#3F87^0(2#10ETD)H/>\013'M(^0]UN1=&091B)J779GWEX_;9S MG,09#-R] H7L(%)\>]O)V&VV*Z>*=N'>@]URKO#13^@8I=DX8F\[ ;3O!G@8 M1N,]]*^K<,A2=,9NT$4RQ/&_%"1_45 **A[L(]DZ#?]B>TA31]D^$J-T00;] M> ]%+(!?2!(E? _]H,J_?>1C\JW/0>]IM[H4R+]](8,#&EZCD+[MO+\\_Q * MK_(II)3%G8H^&J:C" -M8&H,;CD(;_?$3!@O/LK6\B,T."M,$<5X*&YEX=X1 MR(0*N7R(<+\C1_J 2?9?RPD(]50'8XV80>"XE'FZIYNJAG4/>T[)R-OL@H&^ MD4JWLF2J987C>]L!9[GG)TG$&IL4DGL2@<>-CH)'CZ#2F M[/87-JZ1ZC'7,PS5"@RFF:II8LW1F4VH:7C$U@S_85(/01":YJJZK=^A:G>6 MB9P%3'@:EAX>B+BXE\J(!UTC&2?W!ER, E;8K;KOW::T4UX53O%M)PV'HPCX M<+ [VT4Q6GT(^35-[#R0T%45S6[NEO=-[TV(9,N:%I=J;Y7 M@^S.\*%BVH1+NS4+V 7SD38-CJ'X*'V$,*K2?NH&"FXL8[RTXL4V7YA\@\7; MPN+E#S=,.*L]Y"<1W>\<5I[L8,"K<0=E"WUTNY1/J"XUT>LG'&9;N@ TQ+P? MQEWA;?80SK-D\A,OAI2_%5YO(\GZ]>STZN0]NKPZNCJYK(L0*$U'.)YQS376 M=P[1P:YH\+W$?'ER_.O%Z=7IR24Z.GN/3GX__G1T]O$$'7_]\N7T\O+TZ]G< M;-9$H+Z(P-^.+C^=GGV\^GJFH/>]XQZ$4 M_/J\4-HY_.D'S5;W#WQ>5]U9VN_.I+BI0=/O4>9"<;M^DF7)< \-&0WS8:G& MY;5B:DU72EXT7(\XEK"QE2KB M0TE0DRJBNAQ?QBP6VNV'KQ=?T,+\H\I-!1 I+HX.;M" M%R?G7R^NEHRR^@M&V864G^<\S3$@R2Q!EXR(TDK!7\U "0>9[M WVS2?)$#9 M@(FIY#S,0NCNY)8,< RH]HAD""YKGF&N:$9WVS;JYD8S3( "P1;.1@G/T$[U MG6& !2S-$+L6A8;B,J-O]A[V[><26IP4@*/FY.V ^:YNJ+;JF:9!#=\*--.G MU'8LHCJ!\4@83*'W(=PPH'@\!G(!QQ\>C7@8(=U59$VCC0>O.AXL3%"_,B&()16&,C@<8 MG!"?CTCW2;X)E_^]C6A)@1<%UA7!S-D1,^Q'#"B/(HA\)(S[;SMJ1WX?84JK M[\(N_J)8PS;&E&&LFJYG^;I+-$NU#.H0YA.[LZ+2X1'*;2I M/BU1@I[6IZ;^6U;,,E[SZ-75@XQ6$R@I,(R>80 -UXQG(<%1-1@H4*WOY0H* M:[#5!WS;:4P2#IF"7*.[S"!"'Q>+4,<)G7%UU'%5[#FJ#A#/]2BF.K9)0#3- MPQ[6[,>E F+Y<(_1/N8CGER7RUXB'3C&8Y@I.DTC'-/T/BGN;.@5OV3T M;R"Y#V'$X)K/>$U,5+4=W_!LW:*NJ;/ LPVB40U^8Z81$'VIU0"M:^B&>S<9 M:[D_Y?X5OCTMEP6(M)T[HO!-RR:&ZS+L6:9KV;ZA^YIML,"FEN7Z2UC,H>=V M5<-Q7&;7?&K;TB1[LSR(=VA=\DM M,E3OXY6"?NV+9!)]2O*[VRZ4#3&11_-,K_&,!8RX)F.4J=CT,/$M3]=T8O@V M]JGA6DOP[#+)LP&@]9R3 ;K,.&/9'5;-,@DM+BO.T'P,'[_RJ^0FKJ\>::;M M8@*N>Q&/=-AS+5%7@ MD,>PJWHZ<9A#(9,W;?N1NX\DUBHAEB!A8V!64;+9A*"YG*#.DS3#T?^%HSEH M#$F]31U*-,NV3$,U/<[#F(0C'*&36T;R++QFZ&L 20=+7W.Z!^J(A#X^(:,J_A5[/V5YK[:>M8ZJ M_%-F-RTL__2#JVO.?HHR%K'1((D9BF4JKR 0>Y2+&B3"G&%04"KJ?[L)VEEH MUB(F'4'C.4-671=K1+>832$J:8%+B*$:1F"ZD(CH;)D]#;IFS-OPF\6!\G," M&G4N9G.G>A!HV/(T\"JNP4QP(QXQP<]0!W(AW\2:NP0MCFEU54M5'UY4VQ1Y M/UBKG)PF^ ?&/_,^CCZR@LU89S1N?49PW UWU2QA1UJVI[A.IX'4=5W,=7% ME268>)9DZ&@TBL#VP48V>U6F8$JY+,-1^;7TD6 H@5B.B?N,HDLP&H8^XS1# M%W*=N&&!9DM66N]XO7;5J''5Z#ZQKF_E:%Z4]_B;=9-W/&#DF]QK@D-Q>6TJFR")@ K1@5@2"47A+-U[ M\O+YX>*@\QL/,YB/J,_E<5F326M.T[$P]5S/QX9&3#WP/,WU=::YJF6)F+3$ M$L(=]"'./_@8YI]:;%9%!)( Q3IQ"-:AN?+O*((5.W2G[. M;2 2^X9V- <=?[A "Y[T+!I ?HAC[.0@Y<)A ,8*NY_ 14"/8KJYS%<0W4, M2BS?LDW/L;&.5=-4 \?WF14P=>WLFU('GJ$@[R[O-!-W-;W&OIE-5Q/FF6JO M:/D4_BU6P7/.A/J)4QYR:ZFP+@[)^DP&9'O ,)_HCD8@:#/;MPVF.SKSM8 X MMKY$\'XF(X'*+JF1^:!":B;MZCO^F^786K1=J6+.\?4T37/&F[F+=9?Z>N & MGJZ:D&QZ)L6NZ>J^;A*LJG@#N6NPKKE#EN-NV?9-(_L>G;3) -2934$>W'M_ M3TO,C,N=G4B3^E3&$9CE?$20\WFT!JTOR$Y8M-R.D2)KDA\W=E=( M?5](/>;3%?O_@N M>?^5.$];[%\E T0BG*:-Y=OY@LUBINOF QROVHG\N_Q)]K WQ[E2)7C?WU$5 M)/[W9D-XQK$L>%R.A_#+3E.!ZU$<:]7T0997>QVEEK(J[H"'OAF$\,O4C2\E MBH82;>M:GA=Y%F?K1; =:[HO?4U]L5'%CF?J=D"P8>J,X(!1TZ:&3RU(@HQE M%AM%O@5:<#G G-U92%'0"'-TC:.+CP6,R2!EAEZW-%6MVBU*::S]Q ,SV3N=BQ36JKS#.=P'394W:6PDC5 M4J>8^'\2_@U=9@GY-H$,RZA0I4CRM$_#NEMY_7ZVW'O_,H%ANEPSMU#S@FG] M=\,3IS$5B) A?XR(+. -,_J#7TV'6J;=BX@Z_3&6O>]9R[6K$8*)\T<+9'\ ZLVURUWCFF7K)\P].MIF7,#TU(< MI]V"9>)9)M+(-T):I\$]5B#62QM-*KQ3JQZ P;"($?&XHCB198D\9;(5T%Q6 MQ,4SOHI32\7S280LY%C16 Q^$\+0POABF$#"*VOA[#H4CTP":\0Q$15*3.06 M%7&/>'@:Q9RF126<-I=&JD.O.WA2'ZG;6*^X7G)_=8+^Z0?/,GUA7 M. DT_Q2)!R9#(H:YW+ SF"PWR7RF&+O\I4IAYDM!M8Y&N,^Z/F?X6Q<'F7@Z M"HYN\#B=23KJ*W@SF:LJG\IREY8]9$*VI-:7TV3]YXE/FD&Z(*E>93)C3)?P5#+&JO80?=A8H+'"7@&<6$NZ#2439N7 M]9KF^4>>9F$P?K[Z?XW1%SQ&9G%06$&+#DZB'>$*Q'X17=T_K@(5?-/VWT"" MD.;@3C!X%K%MB(-[P^#2>/"IK(P5V!;,-ISLV9!3'5?8EDQRAJDAHJ9SD[*PK MK@!'9-ORM#L Y2B2T?*2L[>L%W,1&\A!O08HO(KW4 M6+'4S3+!5HCG0$U:'/(ELV2E.8%H7U+V5*5\HMZ^@$.U:@[U/1N!]>=<%@7? MAQS$F/!4\/>8<:'GY>9#GNZCDZ@4_X,K=^X3W8G&*H?D8 M'7$N)"9:IU.)-=RWD!"R23@#2R@9H*#W&+)&=,[^^BL'#-!#)T$@!' -ZI[W849(K\CXPGM37E8W M0!(!NI]F;(1HH"%K %S&U4PWO61!^3 MWCZ@?].BRW?6>L''J10M\,4"4T'S:Y&$I"N0)DKE3KZ*]:KF]- 'G@Q1^5P5 M55.%A&O7YY2^(N\!J@KIUS9@5O+OH?HDT1^)C/!UHP@+T]=5U1&]S\_J]!*= MB+(ET L1L]QJ66HJGEH-=#A@$44"(T:UV?6 *)%:Q*6+E8!3) QXZEV561JE MA0[P=2T'P"*DQCDD=2F.,)?9VC\M0U4 #RC2K#'* &M ""S;$9P.1(P6)]M M5NQ/\2-PVE%_%#>+YXN7?2GU- "33#0$^4E.BMRM@3B1*H5QSL0=(@:#6H9B M.1V^"H<2BGWN&2ORJ+NRBI*XWP6.#FOT":^J%,P1MP@M56391*DS 007#N4> MM@#U10V@V#4JRP9SN8S<0W<-4RE=X+L$$/M47:K()40B3X)F&6.5=P.)312R M],)S#!"3CN63EJ6#$N*Y@?[%8#76%!RCW@!>%(/&L(!3BLEE\F M OJGI@ Z+ 3+&LGT>%OEUV?_D>N>=*0]C#F:A3AKC*J-8]^&7NE^>Y!3_J:Q; _2^ UR#U ME,)$_TZ*!Y)5ZS[H$_10)*8-=:;OGO3+Y%0&E+)LXC8EJ3+X"#\C#?BH" (? M60RV$:$OC&6EVY0+P8-RPNBJP3VGM1;H.A%^(BG,-0 W(&J>$/1P!%@BSZ(I M7JZYI_D>Y:I&6/AYGMR*A[>+)ZW)U#D6A@=N3FY//$(2)$_-]M?>9:^.&PL< M7F+#Z0E^T8VL;Y1%5[OBD#1X<8H .A-^$F:3%NLL*>&A+URKV%O=;(XOOPF\ M_*%8] XSZ)DT*_MY*02D[:%Z(;D9RFW*]#J'9Z O, <1*N,$(CEC1>V*EJ2B M&_#(DZ(^A#V,AOB/1%II&=X*&19"38JLL$RZQ%5Q#+M*@?JE]@^GVC^CV[/@ MJ(99^;1#4!J)/M)4H&<1S4%5QQ,*A7Z)P"V?)U9ZNJN"2#%B59X3]^&TW$(_ MOVM^?3Q?_ 3)9VR +"O87M.!D&=J_]VY+WN:1#[9RW&9YUN$,A-CT_,P]GP< MN):/F::KMFT_=*9X4X([*? M?C#<_3_SI-B;L"#S\:2L/B1\+N]8H;R\9K-:Q+CE>"*V%&:L*]P&$Z\/N.%X MM#*9WD?\ANO:0GI?3-6.^EB\VZM5I%:1GJE(?BIK]LV[SEK]:O7K>?KUCB?? M&+\;&)O:+MKY6$;-LR3N2DSP(NG.]U7+AMV7*TM?Y6;B,KFW]!\?G;+*7\)8 M%,WW4+=X//Q,^EY[8OPS$.3/R2!&1_V;/$[\<$:!9@B0FVUJ=]NUO+AB[DJ3 MKD4J46WX^7&]WFAY'7TA@A8-7R=48K@)1=Y2%"WM;IZ@6YZJ.*JMF)ZQ*JW8 M&K&T:OIR:EI530SY]WR7J"NJXX#FJJW6MEJ[-5KK*KIA*+9FMUK;:NW&I@2& M8AJ.8NA;JJ4M8#B\",E ;OT0#/K40\>8#Y,8M]"A]1-KC&Z>IGB."HY#VT[' MT:KM1JOM2K?RS.F^>*V'HWB>6[FY!4-9Q:FOU?K"K9%JJ^7;ZYQ=1;4\Q?1: MP-QJ[?9H;0M%MAV*_,*NQ6&#'OHYB5G:(I#67:P3@>B*HVJ*Z[K;Z2]:M=UH MM5TO M%-2W%TM44@K9:_2N<,",11%5UMJT.MUFZ/UK8(9-L1R&4R&H0,?2Z/ M9GWZZ0<=%",*<8M&6M>Q=C1B*);3UMQ:M=T^-&(HGF6W:*35\E?IG$LTXK;; M7ENM;;=BM>AC7>CC2#R@Y3/[P*XY:_%&ZQS6BS<,VU!TFKM]F@MP I;552K];6M MUFZ/UK:P8MMAQ7OYS/HO>01CX[A%%*V[6/=&*E-Q[38W:]5VVQ8VQ$8JRW+: MA8U6RU^EN&'[=B* MVH:X5FVW#WXXAJ*J7@L_6BU_EN#$]6G?_P/7!!O[9Y<6_(][B1BF$LR!Y/\'Z!%554K?REF,>'C M=/QZ5R/<9UV?,_RMBX.,0:\XNL'C= Z:' QX=4?Y3L22-Q(%--"SA\S1;7&U MXJ*J A\'Y7OO=7G?W.O&?4R^]7F2Q[0[=ZF#=@_O<.0%WW1?_B ZWT-A!CV3 M\K>;':_7_'HU&/+EF"DIB!/@/T^LP M3?@8))2&0$$V8""\X8C%*?P"JB>S(ZS-(ER.:$L0;C@P<+)+IH5WPOCEQ]#^K;SEVFJND4,YOO4-$T]\(+ =6PCH-@Q-$\/.G-> \PZPJ,4 MJ*D^32./< _S'N&9%G&7>S/5$IQGR>0G7MB(_*W3X*TGSOR>,E YV7)&NO7C MXM@R__K>Y[QJ=NDJ4O5>X ?86G"U8&KY0OM'AMY91FB/X$/3JY17DR/-"<=< MN7#6+(?R9?"K>H?W:D7T]Y-&\4;U5\SV#6#S/ \F+QIOX/JS!UX<3-QB!7G! M^G)!6.VUY;+J_1PS?=(2Q!*Q1RP_K%Q>#Y<=;$5U=,5Z0HWW86.14UJ?$3R> M6ZN&OY;BN;IBVX\OVBSM:5XU_US%LX%_QN-+M2W_'E]^666UXW";H+3Q$)26 M,'K(8@K_S^ +%6@PPQF3WQ?@9UW53'29)>0;.HV%A 7./!=/W0-\&L:$,YP6 M #7.AS[C4ZY#A]#9$-#JY0#@)F#.:QQ&$N,%"4=AFN88>D1Y##$>I3D9H!'T M>Q\P_XZEC1*GKYM]3^6:0/Q3UO]-H+^E6XYIV QCEYJ.C]V .8;G.HYGF1Y@ M_Q;Z/R^Q?GFH?S?;7B_TWPBHOY$HY[M!_19CO@BT;RLHZX7RLP--H/GKP>0K M1TF0YMNFHGOK@$D;A]&?CRDM6U-"[@N<3DOF8 :OTP!2DRBD:Y#S0@3$B2QQ+% M!2$?2B08A"DH"AHS7,/9Q\ULA15\Q3'>?Q;"OZ&$-?2 M#473'O]RS^T$;&M8=-9T17_"RXJVDW_/Y==R>K9*H+L^W/7R8S:"Y-.,#0M2 MO)ZJ]G(["/TP:]Z9O9#PSD-K]$]#3@0[5 T M@F+?,RT7^]3T?<,BEDU<.]#4"7)Z)M]F3B;<@\+N"FS^>,)*,)'Q[%@Y@^-* MT*;VW%6<"=^A;Y[IS#QGD^>WR@?5-!2R.H>5A97[ WOK<7DO;:J:X1MZ8/EV M8%BFK?H^LXEFV+[ANYB:U'^EIOK\M'8UP>8 HP%GP=L.MG13UQW;8+>>]U^M M-\B&D/)Z/>U@%S_^"0QSAKL=LSWG+$W1!8ODKAZQ5X=1Y(_G211_GQCW@;* MH;,\XZ$\U?,YHSUQW.D+'B-3D65+P;LGV^G*5 KQY.;IB=YBX2W3[SKG]<+* MHSWAG3T;:@?'"5"!SG&?H5.1@&,B=[:]QQF&# ^\N*S?:_NRT$YD8W'.$P4\ M&3:6^8]SSD6)_X*-$IX)*_B0\"%RN[^@ /JC>[YK83QB3**;3$:95GPDRT-VL*@:O94MJ>L7V(0X_6ZT6UQL4@YHFK MD:N!I8T479Y^/#NZ^O7BY')E"WTS3U72S9ZUBG3V/.=BKVHF=KH*B^?LSSSD M)> KET$O&M:+ZHWS56(&73SK&QX4;5J8Z?^;KRW8J>P[.KAC#:NE!'WIE2=P]UT M%WTZ.;OX#SKNH=^.SCY^YQVPKR1&W&,!CUY"V:#YW+,EYZ7G.4 M17*9\SCA %=Q)L$O9QGFXS45H>ZK7-2_33\?[/H)'1^*#X-L&,&'_P=02P,$ M% @ IH*D4FXQ:7E\50 _( % !, !A-3(T,C(W-C-E>#DY7S$N:'1M M[;UK=YM(UC#Z_:QU_D.]GLZ,\RY9 0222-Q9R_$E[>U>3[P/7@\\1N?[^#3XRTFOK;:6M%)X^#28/H3L%WZ8R/KC*G_KQ;A5UHD8J$[^$#XW9'[-WM/5&42 M?R Q^QD?4<\=^N^)QP9PA;_G/?F'PO]].!"S<=R[[(W%1_A*X)YC''AF2O<, MOP(H!IX#-YS_'+F6&Q/3;*O'[_".C\=6F*X4!L_?\I&47R][.R K9B&,3H[= M\9!$H?WK@1<,@_9_)\.##*]+GN6+/<@G47S=DP]EZ'QB7CDH>R>?+@PMA?Z+ M<*4CKLK@^AL++7CK@)&K) [=V U\\IVZ$8Q\D7@>^0^CH2"QSXGK4-]F'XH+ MK<4:OK/)#/VDKPR'UJ&J:2U@%+5%^MI;N#4(4^*)([+J,]_31Y@=A ZY<,,H MGO+COQ,:PCIA"3&YH1Y#;H]'Y',8W,.O8$#4?MM\0_Y@890 6X=N$'*8+@*Q M0$JSQ+32UTNI[14 1P8O8\TB_[]@]#GL??EV0TZN/I]_.;]) =TB7^D#T8^C M9)*]]XZ%L6M3+UL:7V8<3#X0D)?L:)0.J'5?V[.WY/?OER\!9GNP+1"-@E"E-H#UP=V<*D' MEZ+$ X(: &[C$8-O@$3(7REE,-^!N[_2T!Z1CBIF\+X$O__\A]I55F2N64EK MF)^4T_/78%I;*AXN/__V!?Z[O7G&C#].P7D<4PO4F,T\+YI0&W3;KP?* ?][ M0ATG^]MU?CWX>]"U>XYB*6J/*GJO-S =IAJZVG4TI@Y,AH]Y-(I^/3B[N;[X MXD;Q+8Y=E2*[=YUXA'\H;U;6:MF_XF=<<_AQ]@I><[)Y9B_JXUL7Z!I)^A%9 M-#_NNIG_G_\PN[HVA^/\U>]B9X65TB0.RE>Z^?5!!&@1ZJ?BV_715HN D(/QA(;N1ZC>^R#T M')@=*_!3!)\H0>_+8T=C>'#4*GP;QE&!8=F .]Y_1MG78'M.O85+,' M!G-4N]_5)7M)]EJ#2LUM9,?U$OQ]?GTCM&N%SL3!QW;J+W0ZH*D=0IW_)A&\ MK>@W/#5BNJI7NA>J\"X6E]O6M0VN),S1K(16^*;.#."UE6"5@"OD\-C:!<:(1+"PWRQS2!5"_6<4Z MVXPT?RQ@5"4'D+E06/EL7J@\.H.^VNWT&7A?75UE ZKWJ3WH.+K9'YA]K2^5 MAU0>KUT/AAHQ^'WQGWEG;)B&&TE(_2'\#2QMMI4W^%LUJE4C2LI%;\J$D/"Y MP!>,R#UP"?X.YR:=J[ME6F@-ZJ4$/+_H;5TE1_B[KPI1K[>[1A[M^L5H*\:L MF*Z)C3=Y@3\\8A&B MV(U&#(5)2&,V?. 4EHX,E_X+CP7A SQ#"^%Q>(YS!KQ14^#E!&?ML#$^BQ9" M6?IA$@9.8L<1-V L8!!'Q-1C_BA,=>SZE-^)HS _!OX+F<^2$(.QT<2%<6#V M B-Q"91)WY@N2UR.J)N",#@9')Z_@TG5D)O;5+3Q$N!P9&Z(L90Z0 P M8M=/ 'X96(!8 2G HDBU(T8]P $N&=45SS]G##6E5"=T[W"P B>Z<21T"8(I MQP@P5/HT7![ 3,$ ;T\Q4R:#AEY@31^+^%0<%^@H(Q-[1'V?@2;UO.">OW<9 M0Z)6 \V'VK5(!!$2 &9BJ,VE@AL62&@84"^J$Z,AC 9 M11S_C"W3+#FY0'H MR<":0O.DQ<="8H,5 MC0-8*V@(U 9OVN02A#U%TRCQ:-B"/QT80 3E?(!PNBCO82$HEWN7\89@,(9A,&8 MV$D(FLA^P)BBS<3]( 'AK5,G5.U5:KVV4N,5V2)__3V-. RS2<;4]0 '#BZ> M3H U?[IC4.+>PW3]:E\AU@0&9C]M+T%/D/P!2_L[81Y=2]3F=68B5N0 VP?1 MB#HPJ?3# >&L^^L!LN[!1D(:H0OE=L=07Q^8 B ZD)8H[; MR*[_5P)6*A/*T6-#T)?4ML,$U$,+E+(%JCR*$N[?V4$4Y^,4P9#&N"+F8TU) MQ(#YT2B 'RB-0 I[;@Q&.F@=!S5/B[\+14+9Y#BHOOUQ>7:DFB"3016/7;M- M;D#PW]A@]2< KI/XHL]10$O(%/4&,).+X($8 CT(JVP-1E=UP-1&R! 83B3R(V2#P!:41""MIO M2>P%P8\,:(7A85"PFJ9&P )=#((@YI0M0)VK-5@!7!B+]0,QTI +^5(P9-&% MA?C QL16-4%I4IJ<2)T7%F8R1YA;IR,@6K 2J)]3VKRZ!,_/:)MDG+E^ .!? ME+:J\IAT!D 1FQ;B;9;32MA7O/3SU+2[%%+P$L14%/,RT>L0JP?&)9/I@!N: MSB6=BM)9G$I[$0K**Z%@MM5Y("C&$T H+GY>\KP&"%I;FP=""3Y*@9#3?@:- M$;U#MF4^229.QO8% 8AR*. A$2SL$LJK!&+S[L=2;\/VP##%6%,\RBT((/+, MLDJOP-=Q,,X<"AZ9.61J]H;Z[/)5R[/$W?D\5"4 LP MIY4IE[.$99P'E!R@%@!^X:; !7?Y! #S=0D7*V1+4 M)N;_0%O"C# $GP;BQ-.?XY5F_J%GXJ<& 9LCG3(&!F0G^S$3SJT$F>%F#V MR ?1/'P S 4>#S!BW(K#HA@Y ;P^%MZ;B?"*J\(FF$EC3&D60SG$4):%MT#G M_&!QE)%166PR0KJ)"FODJ\XXA<<;,33*\JP?M_/+2L=@.B#JPB%0J!A4^%<# M-^8"T,84B7#U.)UP2WN&2CKZ&^(DX4Q8:0J0+)Z7E4I@# F$5!"R-?4-/NBQ5)B -2=28P!G'_0KM\HR<9TO M-WM:[;Z9+U--E_(51D)$MJ8*8L +$8IDE0C&FL+C.6D<3G88-T 3,@L$N"$! M#PK,*(9YGFG4T4,4P?S12K\?H3$,LV$@*X[P=SX.CYER?\WG*0M4G_0'(Q,/ M[FJ)>)L7!2 &?[ ''"(.0A&.]R8\T%Z@JA+IL#[V?R*YT7P;9\9D7>N;P'A M"G 8FWA(Z4#S(#F1%% GL?'$"QX8RQ(>!7J$>UJN5.,K"\\8#!5DM >H7QI%U42 MV+010<,%)(HS6_Y6S"[#\V/JHMV;$0?/QHB$QLR-\Z_#$/0H"-/8Z,H>J91 M\^\1KWDDC\Y]JC^+L'?*B2$J+;QHHU=R#[?.B(0?(&6P-AV> QLZ #F !,#\ M$895@1H6Z%?X7.!;Q52D5NTL*%ZDK7OT>((?0NB@P,(HAC!8HE'F%%)O',#\ M'J?#!7J;B A->R8E?^*QGY@@_/NO!":&.7F7#0K1X6^#@6NC,5"6F-]0\+%L MGV-)$.("_O$@!)G-0Q%2GM#:L(UOIW*%4]((\4?)G0N>+$!9Q-' (CFCW-PY M288H>=!%?KFKLL;85?$N$-E=.'Y^C<>> M2^AA;\-RBT H+99;M=:OFGWDV;:%?QE^=-0+%^!TP43(^4\LOADR^7JVV7?#( MM,Q=[PXT.C!H!_ZG&T:?*@K3E1X=]+HV[>CZJ@+D43MAEM%2-@5Z\.@D@GNR M3X]4NF/UN=(B^/_9PO,9X;!0ZEXH_R[AX)YR*XM( M"QZ6?Q_F$F3)#5Q#E'P]'[$;NX[C 3SN1^#I'"$^N8B]#^DD!Z9NOGEB(\"K M5>_C2"V@1C.,%LE^O'V,.P4<7?!_YUR91"E1VG39Z6DH3Y]!RFA:DU(4Q285J'UA-]8S M#3^^E='0T%A16P0^O)E4_ 48NMQ>*(,V;R $+[Q+VF2K_27KG3:NH1V%=#6M+;^II&@W";45+-M MK@:U9\K7/9*<,UM^7D"!>\6F*PC%3E=I&Q*.3X@[L]U_B;C;54$&\.BN19!) M0W$.TKB#L9%ZMG8\O(HL-/2V)J%=!;0[W55-G;J!APV-AM8#.!D6@VC7;'0G"I2 \5!4P!5^0 MKMAAB/1 :*T&$6D-O@[67]E/UPX:J59K9Z$\(@R+/XFJ]J516)';*&W"YP/- M6#72*DW"LAJ'((E'Y)]T#+1_BJW:J)<%#RO-GEG/R9[MI^FT@O69_C*[[>(_5ZS2RD4CB7 MBEX*21P&Y]K%]HE M3KLQS@. 2$MZDQQV\/$Q&SHSH8UGZ85]@Z TH6<+D[1V;[?R^4TUH[E,GXK: M;4O61N"Q-F;.DZ:ZC".OS53'LUD:"=VZ ;+WPA*$[-/":2RK[^BO\0A=T[(C!!@.&G="" ;R!;Z4N8H)ENZK= MB%A9"[YT@_5,QS!LRN'E7=KSPRL*S;&GATJG78*GG8'GVU]=!.$8".GHWV3: M#!\;]?-S+*/28Z=)VGSYL6;%HIT>+CP;=G'Q,RM..Q@O[>K>".K*='-!]6.# M'MX*=HB-WG@?S&*?W C>@]M'*&^#YMK3EH!BRST+@RAM_I)!+6_/GX,/>TA5 MVH%\T5LD_'2<""16!&"/(G'\@OIF61<][,J&XI1F+;@Y]6;=V];7$'PEFIQR M'3XU76.1##=&?_^75(>Y?-.?IFJ&9O+^%$/LDN\'<:'S*7%$=Z B\V3Q-K)YHW^_E !%Q(6?V3,;;_'3 M@T?R[K(YF:;MF]MP)]@2:5?K(ART#AX=A\^!?NV_X=3S6&0'[YSS#!8.3ELB M[AI\UEG>/.2/P$O&C%SSGJNE'5'6TXI#,0=FSU+LGJY9>M=4K9[>[UM@)/;Z M_2ZCSEK.EGQ),XZR;A.O\,KG=R?7JLN&H;>-S9=:E;<(2@W<5VW]WE;3 =W@ M<$02 D#[OQYHE3LG-KE)?W.<\!38JXQF-;/#S!.,HVGM M7O+E JZ#Y0+5[=A_/&0MN7PJB&=2D )V">!XU MRV_@J%G^=48$/"+Q=4K.CGQ6Q+C&;)K.2+QM?;.1>!Y MP3WN7G&CTNKR"+W4L044FW@E),3=4W!W_)GF _\%EJZI9N#SX:!W\?)1$[ MXM#E%V>V#%?0HG8]PJ+62W\=46^@:/A_$H!-1Q'[8==NF2D;3&2LBKH&^(X;19\5RPF-[QYUZP^WM[![WMHNJJ= MYXF/_0*.*8&S%#C/[$FY5[!1C56!(UW!C2/GS/42S$B?7]]4K&I(I5V(&X[: M+1ADOZAMM2=!OR70=RII "U!_VS0ZVU=-A_9%NC[.Y4ZVRSX3GCG65#%ZU7) MY-"67N!3TEM[CO3>-^!TGF-5[!=P]';W.0TA]@LXX :N!ASI!FZ^E0.=D/.? MY/ 7F*'G80_O:MI+-AL36S&BE&>=B"M!7Z& ,B3HM^4P]R3LMP5[35L5]M)O M*^O"QL^L<>\8N:4_R7<:LSH$4O?*M-24=D>F7Y8W29/ >22IJ4O@+*,<8U7@ M2(]M>^'"C>B?%T4-=Q7=VZBN>F;QA01]A5)05HCN$#K5_JI]BB3HJ^8DO>(6 M4?OE:):4B+9%C>CA:7;<9V85O*W ;B'P.E)V#Q6D"U+1VOO M@18+5C:ABH0[^B*5M*OXWTZ1H]*1H-]6::_L#;FM(D=#4OVV0&^N!OJ*NF\^ MNWU>,434U+YXF7E88DBBFEZMR51&)/VEHVR(=/JB)<4:]E"2\Y^VES@P$>H_ MD$$2)R$CDR!F?NSBN?;,9W\GS*-I*TE/PGC:)"*#,!CSU["? M++3=B)$@G <@ 2*.8GPR&!# AAL_$'I/0R>;3)!X@+0=@!<##=!>AX/H8;]+A-1&Y!S&( MOPMO3 $ ,.+OX--+0U5(UY?BZTL?@3G&[J;780#3'R^+K_=?$5[?=5;)TG&Y MFR6PG'IA7+ID7[ \09@3(RORUQ1M?N ?V30: :)C%@*6X$:D428&' >3DVMR 80'7P'E?V4T LJ,^#,&"V/0,F@" MVQ;_!*S9B<>7[@K.#47W7@0$X3/@X%J$B>-&=A)%Z;ON1P]%* &[>RZ[$TB) M&$<&'VR<+H)0X+$D8H/$VXHF6-;HLWKBQI@!I^X\F)#CQ6<@*7@0?(;&B_@) M&>B!".7+) S^BZ2/"C<&.1EE6 .,_GY#'#2E0A@IGBII9(\(93Q0CQ#7BVBD ML#XZ9.F]";9LQENS%XB8?$GWYVG7Y]E5+.5<)%>A\Z+$'B&O #<,44D,J>M' M[[P@BM(QIO8&3 6THN,"< U\OROS'5CE5QK"XK+>BWPUZV'[!>Z[9QG3 MI3!'T*8S740[R6T&>!SN BKV49*.J _$X$93WERJ@5[EJ9 G^K8_]?WT-2MZ M-KP;>+_?40UEH%FJU=>[IF(I?8,Z2E\Q%692I0>/>: ,1)?\+VX4W^+8:_&% MGN7PS+H\94Y/F<>BK.FKK]O+_1"4*O#MA:$L'>6_\UHRN3,W_1=N_:-' TV@] M1R-4G-A:7QC !8M5? 4*(P$1!#> 4#SA^AQ8P'O@YG29')A:^B$#60"LGQI4 MSM3$SGOZ"UZC5G#'EJGM$E]Z/IU18-YYV?#L QY>)@A40U4,IZLZ/5O5X;]^ MQS#Z:M>T6%>QU9XB!4$E#"(%02H(/F<,!.R5GXN!G)697PX8\0]3!2RLLZ.]<:4%79G _YG@Z2-LD$II8M0]@K *,HB98L M06FTD<%,4V.T8[)!Q](=U:!:?V Z)E/[/=;OJDR*H$I84XJ@[!"OV8.XZ)8D MTLNE3EO5%B5$F<]2$!HSIX\I;7([ A-+#)6_2ES1.B3Q!_0N$ $D&J7AI#3B MQ;,F$S%;N+MC%)[W4X?(]1??63CQ#%9SYSK"N+M@5IA@TDOMB5A0/439DF,2 M,_IXRDX_X;F';&H/W;$XN(!BMG\EI^Z.!LB:^(1BZ6'$Y9 9ZE@J_HD MQ7,:^J!I(W(:^ .&\8V8 M[X+]!@, ^? LXKT+HF44@+M'?1 WF%V$&^SI.D%X>R*)PP/ /"@4,F0D.1$&,MS#!H M[SL*F;3';7)]2PZ-_*_SV[?MYXNDM8'\=H2Y ]!V(+=]+D]2<]F-%D"*7SC! M&%/C-K\"*@85QV&_TWE+S*YVI.J&V>(@/32-[EO2,?6CCF%V!7OP] 9*,U^4 M.WCY((>%5UV>O2<=0^N:??UM>PK]+YC0I(GC!EG">7YZG"XLL)'=,6"6^BQ( M(@^#_I9-HSA33#G!A,Q+:S,BD3/*$]EY,A\>C5R@!AJ+!8SB>/+^W3LW;.>4 MV@8%N19/H$8T>*P(TGE4 2Z^7G>0 MH,"P(8 ,ZX%3(8YPV#>,MZ1OF$>:8G3+B0ZN'>J*_G9*'D:G=]31%7'_,XF, M(!-D9)+.&,PM5K@_7W)HCX 0'9&WR]C['/T=$;UJWG%A!$I^@%%M)(FF?@Y3TCL'LMQD %8*01:7+" J!HP*?G M8L*>)_Z'8,G$(#.SX4").(F=:A1NU]_!$+G2"":3((P3'VN)1)XWFL((+&@V MP>PHR!'06C"D!4X3T"P\#-2GFGU%4&F6#PD& R3I$=@S1YB[AE%A];:+Q'J$ ME@RO,1,3:F'])S?,848A,16TDGXPF"EP';R1Y\]]EH2B=JCP]OM1D.O& 'R? MP#_"8P7M@ (7I-5KE(";@TM#^0Q@'(LEJX&6 M(Y_8?1!Z\VRP7NI^(A.\1G<:+3-$E>L+60Z0:1%@%4R^W;D@^LCER3@'>@YS MU)IULH+*R(+3!/!3D&#V(=&UH6);8$U.S@8"I,"J:"NA23VU0I*@ MLXI%^/'*@O3<<+AARB@^+&CNODF T8L*(9FYF27&C/YL8V9>\1Q\_,I RZ-+ M$@-OO\\LG=RQO?W^^?OWVXLX^.WVZY=;:LTZQ"Z7CZG75YB9T5:$7A)*1OZ4 M/U__8D?\#_,]T%HA.13$H/Y*GE%_JSKSZWSRA_7+2)4R_=,"5?' M+X;D%_FS]C^?SX.O;^^B=MH]'37*_#&RK[+EJXY67&8&^M3LW!R,SD/7)E\# M/PS8)E][(X+F9[PH/ "_-P="04!N@U)T<^Z].9$4KZ\["[<#.3AC.<._,@-7 M]_S; J$L-S*:$E"]"$+<77CT)0A^8,SI)@;O'W-=T?R\A+!_D3S5S^!_%Z]E MYAEJ=&-XDUVU-//'B$0]3%O:;\'CHM( BC12%;.")<@K<6<;CNGQ?S=PJ M"TLCHH"=1H&/F8<6!DD3ZDWAD.4UQ1Y5Q\5 ,<'R$0SO>@]9P7H0L4+I">Z7 MB:)D_(R)M,DW_%[4U4]#6EB>-@V79I/!T28L%*M>W$ZZ]"4MOMPHL?Z;[@Y( M:W]Q;*SV][$BOYBC#=WHAXC )[[-0B0=1%\+\\\!2.EPE M$ED8>&URXHC)(Z2FSXC]>4N&QK%$RG-,^?;MV/7%UE\+KX\GGCMP :Y6NOGO MVQ^79T=8Y@>/L+%KMW&?; ##87::VB+ .-UD;-,D$GNM!*(SD+:P"HC' F$R MT_7SB+P]0I)+ %#C@Z>&R\E#$RSC7EAM6",?#M=RH>"0'!,7)A8 MUA,$FU8&S6[M+C'"RG-$SZ@EM >68SK=KM,?6'I/U>C Z#+=L)AB:)9-NW6M M)9PI?EFA54-';0N?=%:%"36V0I<&K;=:%>)&- <7U=W5VDLL+R1?+&%*-&-B6\+T^8"0&#B3;_(D,^TR,^69[Y$[X3Z74%=S?(9MCGA?([&I+[4K M@T&KJ//JQW(:\%>'.4RS.TP'$]-2F:F;VF#0Z1FVT^M(EI,LMWF6\P.?5UFZ M>2.:5NJ5A>AHI^R5>6<,[@P>F/#J4DY#/^[.#;RLKT8+MYK "SAG_-Z^:8L6 M)FG;"X_>PS3#Q(/9+NXV$:ISF*1BH'Y,K)OFH-?OT&ZGT]<=BX%/J'8&IMIE MAF-0VI=,+)EXLTQ,'=R@!1YB8L$%WF!NML-6L;\.23>PBB8_1Q&0.&^/E\9U M6FF,A<MM@W8=S>E1TY1*6_+[AOD]+R7'!I_)F&%TE:6[ M"]*N8 Q&=VK(3+H"#J?9H0IC3&<:LXR^"G^:>L^B)OBCDIDD,VT^M,K;J<8N MWR'@4YZ%2G-6^98+T5Q7Z,CZL96A]C3;Z7=5%6S2P6! >U:O;_5TM:,/NF9? MDVPEV6JS;.6!T><5G;D@?, ,8U;X ]W7$.%:74T M5>LKE)J&H>M=:O6[P-:687<&AJ9W!I*S)6=O7F&>8F=Y/R;?L(*+\(JVK#M\FK4\Y'4%6*I!70]5K7 M,1O)[\ !ZL>'IF:8EFU;AF': MN@$:MJ^8&C4TL%U-4+0RZB/Y<,-\F-80S4=Z1&D4C^@4-JX#NLT,5;5-RU0T71^8)K-ZK&-TNXK9,[2^K)R1 M[+7II(7_D%>,8J>(,)EDO1!F B^\:)77AO+(C+B91L*/%!O>;1K#A3"8C%R; ML+NTV#>MD+NG(4]YL# ,0&6.2U*.]@,F,45]]@-RN>N(,;*".A[^>0>CB/?Q MH7D-KAN"+* AUN[6C^?5CJ4;CF)T^KJI6XH)UJK3H5V]V^OU>YII2YZ7/+]9 MGI^M- .2GCPIE"SD^8$?>S)[]Y1^V&F6H#PUAAY;0#?:@"WYJR+VY%L/('H M+O#NT@Y2B^P^!OF!G3#A#6F3$3P+A0\N^#OQ :PCD!9_@^#A)?,A[_\&MZ6A M8>SFQ(4$+\>=]M&HGQ PJ=:G':O+M#X* <+3A@/R>\]B_,MNIPDWRV;B&W$\:!P[SZ\9_695W' MZMH#I=_5>R:XMU15':WG:+;9&S@R?BOY;SM5MD('ITQ7; 45,WODPSR&: H/ M0K2L$YOG1,7&-#_!K65)R,^[HGB0X%; -'4:)'&$S=ZF3]2R)IS7F\Q$#43VE34Z\8UK$^@)M/[8(2JP%TZM523V@.&Q;,FTYR!*NL3 M))-MF,FR"@!>;."GL=SZ,8[C*+K5Z5+XI^EJ5S=[=J=G:3W3H>:@UW4DXTC& MV:+YF$PP?))6E&,4A8=*&(9$TT@)#_/RV$Z^/6NQ"W_,Z+A^O#?H&HJJLHZE M]S1=[SAFSX _;:>K]*AM&3)G(GEOTRE_A@VUTS(Y=SP)TLR(C>W!J6B0(79$ M#D.6MLP88J-N/]M]@;T)K9@Y&#+9$,>MN?]6R1N:UX&K*T_!F>_@\E@?\F<( M<84-=$;!@ )W0^]TNGU%,57#4FC'4@V[)^/?4HAOI6Z+[W,7QP.D7:/X_)&N M_2"N8SJYVQE01;%5C5)#-YU>7]7[ND%U@_5[:K\G71')2=O8!\=/4VB5]%(3 MG20P"1R(.N1TIVE^EE!(_6C -\^Y-M]L(%HD1<1)1)^W.^HE\)B#1PS&]"=+ M6R>)R!M<6$PMBV1UC*>YN-GMA81UYBJYZ;%"$^P14\_ @V:;!M-95]-[3 =U M:2F6VE&9-J #AUK4D-PNN7WS@0?7MX-P$J25EV!8LC3T 'R7MT.C#_ 2]40A2F(!@N)GCFW(2&X34/^3$2= @U_(LIC^8*)CKN5E M'8+!0&ZQ]>T46GD#56Y^\*,7L8\'/B.J97F)C1O: MR1AN%4T$,)P@^H3P(\_$SJWL<=YHF'\;V.E)TSS8FV 0"HRI":>9K!*7_;39 M),8&O2'[*W%#$;,"D;V1DPS7&GK:B>!3;TGPJ:KP4Q,"4.7$4RI*GA(F53=T M_S[M>_TM[WM=P6QS2EQV^"87Y#>)%;F.2T-TJ9X]]&F 0A6CU+AC-/!<<13= MM"<]KNH2BX+9O(%P>.D3@)DG_*94AF [,J&I0!DE\/S;IR7 ;"1QR3VSALU* MAIR@VT*YO:+W3*;T6,^T=&9WS![MZ;K6[_4UN,G@^6'=>B&2"&J0!X>16D 7B#H3C8]^'N3A9<@/7#B5? MEP-J<0%/!21#EZC$6I/7(>ZQTJQDC=@R] MK364$26U-8W:-*,OQ7[MQ?Y)Y%)R36UWX-I2_%>[PIHQI*YTVGI#&5)26].H MK:.94OS77OQ_93]=.Y""O]H5UHP55;4O[7Y);1NC-KUM-I3:]D?P\_[84NY7 MN\*Z<6+7;'<:RHF2VAI';7U3ROU'Y3Y)ZRJ+]7NU4 8W0<+;T3KDE#<)\K:= M#5\"J6WQ,5E:=SE3HKI%=E]YAIN6"F:WK=17*-0"L9+L=Y#LU3K7>%2!V-J[ M2K.[!YY J,#GLDU&Z?XH451O<@3_&82>W2OZ4:=BPBD'_5J/TI AGP.L:OR=1@,W%CZ4=6NL'9VK=KOU5F;23]J MQ^A-4;MUUB+-5@^5X>E[\$"]^(%\@\F&KB/C:3O.EWI/KW-J2&J!G:*V3E]M M; WD_NB &W'<98M\9CX+J2=:"Y\X8]=W(WYZT1TCYS\GV&Q+ZH>*5U@SCC64 MYEIMDMH:1VVZV5AK9,]S+=]XJ]ZT::0_S!HM1LEDZ=)P3GQ]H&W84=9<4YT9 M/1I3S^/M'WDO4DZ[V2]U]U(^FL!6-$NJJ5KK!FSH.F:74N]Y6NZDY1FVDTM@IUSSW52VPT MRZ(X"V&VB,^V5NX@#=M=,6P[O3IKGUH@5I+][I&]9M0Y8KL7M8$5:D9TD\@G M-@A"ECI-Y!8/(Y6N4[4KK)DQJ_9KS<72==HI:NLITG5JJNNT?94@3<==,1W! M8ZJQ'*@%8B79[Q[92X_IB96]5$OJ-=&2V(MBNQFG):"IB[# TW6=(,[?, MBW4Z$Z:^4%+U7IU;(*P.N"VI:LE]DOM>L46GUIG&2IAO4R%6&49:8QCIV:^6 MT<):KG 7T+P_.9L_>=D\OJQ,[)_3T'?]842N62@B MKC+(*AE"HGD_T=S,>K<=CKS*"AQ9@5.ED]?N['H%CF0^R7SUA)+2[M3XF((& ME;\URW[8"C$IQ*JU('9=B$GFD\Q73RB!!5'C%,VZ+(CB7_ UA0$+=\S# M ^'_D1Q;X5/W'*IO27FO9X!\2. ;^"]DC(P!#Z.(,-]A#OE*0WM$.FJ+:(JF M\O,$9BXI)&0>C0&Q<4!L@!EU?7(ZO\>G!VA?"Z:$0=AJS$/^2CI*R0 M,H<"4I^48$7P"/\V8R-% 4;*.HAK_+DY(6)1^\) M%;F.2T.718OO(^0T #;W(^!T^,2W"P,S.^03]:AO8TTZ8W')@R^:Z.&E3P# M'DPP>ELVFQVS:U*M S^,;J>8K54Y>7UE,3=W)S06\_$7JC/W@7$,Q&V[S2\S2F-9YR550M-O\K7-%&K$]U)=.\5NAMBJ5:F M&J[#8 (3?6B1B8<[V3'T@W5=$]S=+A/2^V0E=/IFPVT$27D-I3SSD8[UC:"\ M?5,;TT8K'J,1$V1T% R.$OAC^\D"R;V/4$?5M*!INHQK2,K;"N5I#;=8]DUO M?*7A#X9ZXT@TUW*(Z\?4'[I8_UK(.T^OIMI$NB+[Q-@=M=-P@U!27G,I3Q;' M-DFE? X"Y][U/*D<]H1%S9[4#9+PMI%&592ZEZS51C=47P-;7>R*>QC;#U+) M:K[=JN;3#+WNT8B:8%CRP,[R0*]3=Q79M(K69YR14ZQ7L:M6T^-.L-*:W6[W::I^A<>H"/Y4?)CW?FQTU)ZW;:Z%_PHRZ!W*HC5 MF+I8B>Z]0K<4,Y+NI)BI[2IW!=W[EJO^WE^0TYN3HC-[^=?#__ M[=N7L_/O-_\B9^<7EZ>7MS*1+9E&RDB)[FPF>R8CL_X(7UQJN9X;NVP+IP1( M'FD4CTAT[Q6Z&R(2U]NU[<2V@\2/(S*A#]@^>G]EI(S.;Z4:3E5E':9D@-V_XMZ-K#6=@27D-I3RCWW#3 M2:J.0J1J$L 2 I\$ ^(%_O H9N&8.,R2^Y7WA:$U76H227C;(#RMX:U7FKPC M;;W:Y=O, 0S>-!M2JYIZN5_G:<%0X_TZ1K_?[M9;@-0$PY('=I4'ND9/[EG; M Z>M]!2&+_70J])H?H12*L]$>6?PJ^42*18GN?";-$(OK#8Y_FEM0RCVW"O2M)>4VE/5XRZ!Y"E3GE:IQ3M[V#N?)N:I%\E8S]"-I4S MME+[O)!4*3M*>=V&UY/)LI['RWK\\EB/+.V190V599K,?M-ZXLG2GII"J+D\ M4/LM/DTK[6F.OIVI]ZE)G8\4,+LE8/26HIE2S4HNV&LNZ+3,CE;W@KJF*5H9 MVZEBE;N2]97HWBMT-R0A4UW3OV \=N,QPWY6> KT*=P!!@+S;9EQDYI'BFI)=W5D.ZDRH")75/7.7)]8M.) MB^4(\)']M%D4X:ZE"0UQRM_#?,Y[6S*;W#I>4UTS*PZ;7S=XG)_7)!W[X M2S)./!HSAP2B460PGH1LQ/S(O6/$"R+IF>P+3Q]JBM%6ZL[4FX?+6\D!^\(! M:K_V]6?-X "I7>>T:YH(D:)D;T0)[] GA8E4I_O+ ]U^KZU+#FB2.FW.OBRA M8V]#1J,D?(!I!/8/N2=+[D:I3'IUM'[=3T6I,?BVJN8E+TI>7 HOR8M/0TX: M'$]L!)\MG6/LE68P!* T1R8W7Z=2^@JC'X&FB MR"86NR IZE,17Q.P2L*3A%?OAB4+=*DWPB$L= ;CK0?J[R#J->-WF ]Q@L3R MV/8-EE\VCZEGR9TZP4IK=;O==K]9QO%R &Y-_TI^E/Q831LUI=:_Y^ARG5\/SFZN+Z[ID'T*&?UQ C]R(-@>HR%? MZ2@W$\"TF3,+,L[A?P>L6;&'Z)1EK!@)S2:$0NO.#^^>,? M7OH$*,^#&4=OG[_PP]]]FC@N3*G\X8\K<.XL)7)I "_P4([9H(!_/5 .^-^I M0N9_"UKB'Y%L_^YV36JJ%NL.%%4W^S9E\+EC]AW'UGN= 2UGMG_^H]/_\%<2 MQ"5LM:*[4J31>6Z8%WSEWM@S?;&G).ZKM.H*@^>#=><9>]&#G?*GN$/X99XG\&0JM4^H^B MO%1_[P09+QU<>V+:=2"JX^0CZ;SKJ.\T10-#,BG1Z/6E*8G<)Y&;X59I&F[7 M*2^>@YLUM2\]N?F-7'SY]N<-N?C^[2OY=GW^_>3V\NHS.3F]O?SC\O;R_&9I M*ZW&\<*S1Y82I-906Q]O/KW?:\-'K#/PMWT[&"]MM;$6LGK&YO9U[F)Y"OX; MB_VM!\@OV$:SUK.']$?VT&Q)#%1.B)+@)<'G9^$8[6Y#Z7U_-.")\]\D2AOM MQP$)F1WXMNLQXN>J$:_C7S;&#B=A<.;:2[[U[M(_8Q,P$5W*\]:8LJ;C M );R-[\@Q>)&^673_IS6E?$+26R;(C9]>JG>5[G6O.N9+8&D=L2F.);<_5Q%7@'_&(LHO%,2R* M,_T@U4.U*ZP9Q_:6;VBH.<-*6FL:K76E*H>(5UHQ9S;;14&:5 MM-8T6NO(DL5F*H:+(&3P3CQ%:C6.\&P:7@L[=@KZ7TWZ/V1HUXEO3\% MC-HKQ.I:$G"W*"*N3PI[&J*(Q:+-J3=M>RKW-U2\PETH?)=HW@LTUUX@KM=# M^,YLYMYA8SD9,-HL=VS<;M+4Y0>1U8%)ZVTX28)O','WEK?VEO3^%##V7"]F M>?>2QK0OH"$I)FHL)CIJOE")2:^X/P?=EGE6JS1>JS1/;#A)L M.3BA#QALE<*BVA763%AHG7J;V#+MM4O$5N^POLR]+<40_[]=8*];8@);TWCMZUFJNF>A/\GFO';S-!Q4*UGI0:U:ZP;E+#T&2! MKU23^T/P9LVUY-8=N(7SYC5^WGR=]=:V6'8)J+;%QV3I^;?/.BI]C>R^\@PW M+15JO)RC2YW!TJT;P7:*Y]JJ6Z MK@AH?%]\^?;G#;GX_NTKN;SZX_QFSO:6[1 DBT@T[R>:]T<27B>A/:*XA248 MX"G?$YCS0XM,/(I[6'R'L+\2=X('A4MQN%$^V7C"N5/S:EV9<)8$7VU=EBX) MONYU6;4-XN5T0&83"&&WTW".&7G83,(3;\ M<&,RH#9N*W]H$9_%6 G@N!%OU25EY$:99],.B=93ZKS!3HKJG:*VCE+G?6U2 M8:2MC5W?=B?4PR:-6/<5D3.B(2,AFV1%U5(N5+O"NLF%KE[K!B5UEPR2XAM'\7J= M=U77G=[WO#!,UDS+ZI-*NB/56.76 J^2ZG>/ZI4Z'^,JJZ:KJYH^3,NFW\YT M!RNK8)"J5 J5UYKSIEGG4&YM 2>+J"7OO3;WOO-V["LU>AC@X7ZZ=7 M]5I)%Y@-<8+$\MBVF?>7S6+H61*N/E#J:DJ=MYRM#K@MZ7;)?9+[7G$6O:$U MJ4?QB[BOQ,(H_@5?4QBP<,<\/! !'X^M\(E;B.O\>G!V4D1R#;S8Q;"(,>( M]Y(G\Z=>1T7BPCU#JG\/E!".J9?=A>/GUS ,=/P.O_BX2'+E$,RG.($K1Q9> M.J(#6-9[0KU[^A M\,SQ*(3W12/J,"1'_B$?)26GE, 4$)VD!"V"SOBW&2DJ M"A#C*%VBQI^;XT2+VC^&89#XSM'<5P<+JUWX>X:V;I+)Q&/8D()ZY-(?(/!B M-_!GGUH@RL6OEW/>J[?_GOYV?O;[EW-R\AZLU--O5Z>77RY/;B^_7:%]>O7M MZNCSR-F<.;>B1^R.Y<=L^.)YA(N%"(^*NG,=1LX"SZ-A1%R?P#L]0 B,SG[:;!*3"0N)V!)]1F/ZMD:K M/''^FT2XQBL6 S'9P9CQY>;7SUPOP=_GUW5"SJ5/T,Y!L@=?CKAQA)O-@Q!G M&K(H\> "+F.8N [U;49 C=B)1_%[0!"U;>!T_L6]&X\(4F.+Q"-&3H,QZ*4' M,J*(2=M+'/%$/'+Q%2 ,(@!0!ASL$>;F0)NR:'Z#,X5>"ZF ,RN^=@P#)3!3 M&)C&_,TWV%$&5L3$S,]_VB/J#_F,QFX4X4H=-G!]_#XB__Q'7].4#W[@"U:" M+V!<%R1"-G*;WZ)^$)J/?*4^B$B4&L1BGLONLG='B3TBCXS3(O$ M'?C_37R;0Y[#K@ U?*/:^U# 11!.@0)K9S:-"BAJX8",POMM!.LJ.+*IGW-< M$K%!XL$""O+0G_WA#(*!5L0 @CRG8"C>9,&R'>PJ5 !8"9Q M^(!:2B%P/W+!O'&CP!,OQ2FQP8#9,3^Y+D)B!*DU3M%[1\,'T?!N89D(UB#! MP^T>8,FAF+%@*/B3+5D8/PK/<\= * ]&VPTBF0!TFV8D=1XD=:FZW<"H+88 MEC;P8,Z/010D:"IZ8?7> TXD_P:[,DTGU4Z)_+9D,,XT0E( >):P[B+'@M;W M>;- E-T1E]UC^L"G;K&,0M#0!&A% V0_=X#B=W8@X=S[DX0O]9#VA**/^6[ M16AD5#EW0_ZNG"<04&,AB1B)Z!BGX_OP#(UF!)<3I (D MQZ3C9AH;KP^91R MD#^0*L#VPB&H!T:3SRDVPB45P ,W%,38"ES:KI&B^(/Y[.\$*#O5:+R/5XWF MAQ3K N9L+EZ0]6%P IH@9+X-C.LE=IRDO #@GBX'48QXGX0NP!Y0%3)^>&61 M%F!@(1BYRJ"I.,GDV BL52!9D)B"'E!0,!#OP1@O3DDT9>GP!XNY^$6!G2H% MN#L"21S.458+U">*3FR>B2=I@FC#\6,&K_-03F1+!D(KXW\<%L/$M"@#'19- M7,$'L()!Q&(NFF#8!&457Q,PDA,""8=1"A^8.5)R1-%2*\*/RU%0/"!XX04H MJ> .+KY\<"S3X:8P>'2&^1M:!,4$5-ODMN =8A:W2Y%9@;MU%!K942<2O)B@Y5K+70YWK]@F05:X!$5&-'#X# JA%\/E /^=YK5 MX'\+?/*/2#A_JY2I' MF4#S#.W,TNA<&+(TJ_V\_/6SRSA>F<.H]GW=QQ?W\I*+90HM%8N5I^AO1R%C MY"M<'T7D''Q5ISQALC*(*DV6O+H$HR0](HE7VQ7B)9UW'?6=IFA+LGP-)5I) M+NLAEXQ:EA1;-I1:UB/BUDB>SQZZ=,_XXQJX#N1V6$BF+=D"LA62VVM:6E&J M/7O<#2%(PJL.!/W45LP-;\0L.-&%@.@K)4[U&\[6NMWL<21LJ/YN'CO54+>E) M]W M>-93LY:TS?^Z#DSG].F(\I8E[HD:5&AIA0 M"D),^?Z5N&%6?N2Q(?4P'!PFU(O(<91,EJX49\Z7Z[D^.\H"YNK,'*(Q]3R> ME#A4WY)##?[K@$4/PY;4>JZ+3^H@A-8G8FLE!8X:)P(D=36'NOKZLFV/-2:P M?= Q5X%_9--H!-HD9B&+8L*$UA%%=F.L#/E[FKO,[XZB1)3I!E$<5:AL2*YM M=*EM*EU=K>2!L:Q;3HW%@:2O)M'7DHZ+-::O?5 W9\R*YY1'T;OAI=)/G-<[ M9KZ#);)K4#I"X:0(JM"!,J0JJW1UM1(UZK+]MC46-9*^FD-?BO2<:JG*, 7% M2B)TIWCRT9%J$@"QP\:NO39%)=5)-:NK%;OKRQH6UYC=)7TUA[Z,!M+7^M7) MRLTZ-ZMCTOW],?V9UO"+O8%8QD^MX"[=-[Q3"F9M=<9;ZX=7SSZ'ZSWQHJ[A MEYH"[+6EDI+3]I;3^G4M3JHIQ%9GM2U8'L2VK9RE& MIT.U@6TQIDQWV\D^!'7:FRO[$"P#T3YLTFTX\>[,QG+9AT"2B^Q#L/-[QYO: MAR W2F47@II04L-WU4MXU8&@ZU4"=O:("RZ[$I0B95>C<9NO.NXL.61KVT&V M7:\3D_2]B74K[4Y-@\A[KO-D4X(Z"*$]*5:530DD=:U3QW1K%8Z2.D8V)9#R M8)OR0&G>5CM)8(TBL)H6Z^ZYPI%M":0R>_WJZB9K:I69E\ILQPBL>;[Y/F@R MV95 ,KNT7"6!20+;"84B^Q+41<7(W=+/D!XUW?M[6%^GJ*80DXT))*N]E-74 MFA8HU11BLC'!DR ZR?87ENY!S'R ()EMQYA-:?=WM]W(:QL@E#8\J+8P5.AJ\HE&8 P$OJ@BM1!; M,["[09B(Q@8C%K%IY!P-"#^( >Y^Y +$N,T1V2&+T]A&FYR(M@Q1XL7\<7(: MC %%#_^*R"#Q//( Q@EA@P&S8_EB;BBVLH+A]+P_Y*: BX]A[X^\1;(E@1P-!B MTR72B(\T;5?Q!+X0(Z[(HZ0TY/HD2BPQSQBM3S=P< &@/+ L#7MI+$R>+Y(D M_FQAP3+8CND#&=$[+'E+9X6DC-.>DG%Q^?,@+4=8^;1OIT1")A[U^723B:"2 MF3>68VYNW(S?IDR6O6D%4;!R9Y"9SRC-L:?'VE\-08_$/^0BIQDEUD +F%"E!A5!%_-MB(Q2227N- M/S>GIRUJ_QB&0>([1W-?'7Q\E%*6:="#(O4]ZZD*]5<6Y";G/VTO<8 >D.\. M+>:S@1N_?9>7PD9ICZ#H_=H7F%/+:HUV>'<=G6F612VF=:BI]Q@S3=;O=&U% M'0RHXK!>52SP=-AA66N=HOA<#*"LN2_)9MM,5-A0)P5K&C(KST?5LY/.BG!9 M9XN),N M0=J"H;W/)/J\/BAU)-''^^4TBS0E:6RN-TZS**-ZH;4V(GSFP)4T MPMEX&QQPS.!A#US2J#2_M 7JVD/:>7TKEVTVZV M;JNFW8#4&T',M54[]Z'F]VF[%+9QU;1.P88&PIASU=G9^U7+?UYH/?JZAS*DEJ#:N M:B5G-9RS2K=32LYJAM(OWT"Y6:5_&\34*Q9S%TK#MRZ-GMAHM4%IE)6[I!MC MGL;<+J9B:@<4$( U=,]K!Z;MFQ62D24C/\[(_79IJR?)R;4S8V32J?(0X-8* MUV0N<6_1*H6$I*8:+5ZBM8YHE?O-Y);(C=!BG787-9A$F[_O36Z)E*0AMT0N MF7T#MK4U2HJHO MCJYA.<$^9ABW7 @M]WY*P2!5C:0H25%DUV6]W/UHZ>&2]:IKK@6LMK]+0;*69*T]9BVY^U'N?JSIOA>Y::JY$G#K M<-J^82$Y67+RBP[&EIS\>CLF^W0\=Q+EPCF4BX>@%4:I_$C*3G:DUZ6?'NDU M4ZHR/9C02<+LX,>8U^^/1?T^P_I]\I6&]HATU!;!REC,1_[2[[25[(0'$RHRRHP0O3J]/R)C&,0OQ#+_3D>M3/%@, MIFB'K@7O=/VY(R0O@G ,.#KZ-Y[SN##3(FY*)JVV%\[\JQ#,>@;F[SRHPT\Q MS#.V65HWF%^0UNYJQAO@(Y^_'ZD]S0+X 0[B) RGKK=+:*;2Z1O9]/$X1@06 MII\3/TYC5'PY(FD!1FP2AE/LY&F)]%S&)](8+7(_ M@I%^F\. A"?FZH'Y"\VCB%QW3Y"$X.*"0P+&O#@PQAO+73 M67:8/3GA,Q)'C>)AMS'WD.:F4SJ;F2,Z;_F9KW@2(4+#%[II MJ0.]UU,L7:/V0%$Z1J=/'=6:M0OF+9CYL(*P:M+%IO/M8LS@F3L=RL91]7:O MMW2H^>>7!R VM2=O@;WRB:VVWDZ[OR> NV?>W4LAMQ#K>C59/C>:_%R0OSBP MN'G,_$_B,])1A'6W)F)^?<1\AQ%PQFR&)TKG)O86^:)2J?.LH38D"9>'==8 MR]5I:TWE4JG5='Y]0SZG9M*K.+SN6D9@]Q>UK?;($8'?G=(2<:F>EP!.;^LJ M DYO][RM)2*!]*I%=PQ$49?2X9O;7S9H, /E@0II5GR*D)N,L(Y4WJU.IPWP/[E MQ1B;9O^3^>P:QHF&ZXX3S1,.P"*K4:D=Y?RBMC4MC23U-L6H3]2?[32\]7;7 M0'@;SPD$+#!L(8D[5T944DBTD 8N21H?JF^?*DD)DG"F H67GI1FH,&').<_ MTS(BU+WN>$)M7C.!DN G R'(1N*&?,"%OC"=;#&:OKJ"-_-J#WB!LI"N1,,0+$>RF$Q M=;%@'*86Q*(62.,!O(ZP;]JER'ZB0F#I]]//A4_(0)B#/[NYOKBF0W:5(!1. M8(:EQ7XI8QU\/$;F*'ERU2J#)UA-7+A/K34_",%"R^["\?-K!Q^QUA&_R$VV MXW=6X#SP#Z-X[,&'_Q]02P,$% @ IH*D4ASO1=)Q P A! ! !H M;&8M,C R,3 T,C@N>'-DM5?;CMLV$'TOT']@]4Y+VMTT:V.]08K=! $V%VQ; MH&\%38ULHA2IDE36_ON0E*F+;['D!'JAR#EG#F>&(^KNS;K@Z"LHS:281^DD MB1 (*C,FEO.HTIAHRECTYO[77^Y^P_@]"%#$0(86&_3X\/[M<\ZX-=7HR_-G M.P3T>I*X!_VA),D4RY: L0.O]4S3%10$&:*68#Z1 G1)*,RCE3'E+(Y7H!:$ MLQPF5!;Q57*5)C=7MU8.AP*$>2=5\0 YJ;B91_]7SI)!%B&K7^C96C<\+R\O MDY?KB51+2Y*D\3\?G_[TGH/MBN??=5I;VJW]U^-=+Q0/S->Q6UX0#8V(/?NM MCG0ZG<9^M3&U1.P$-1/:$$&A:Y^9!M U?A77B\'4)LUL2F@#DA.]\,9AQ:+2 M*4Y2?)T&D%;F&*I9.@ 357%X$YE1L0/%U@(4HPU BC,P4N =7 :LOWD-=+*4 M7V.[T-5E2PTA5VQ$"&F(L57MI[:39%$2MUR;"':%K,7]M3Z#11$T3V6O1JR M)+($99A-25N"\8_:%2>+H;NR$. _=SN.YR^[ >0&?S]_.'*"O9P'22O7,MZ* M[%$89C8?;-)5X8,>(9;-HY,6C>?@.X.<">9K*;$=)4D01H&A.R0B0S4=ZO#= MQ;LDN_R5ANRSN/?CW0+9HK.=0U1/]H^<. MGJTYJ0P2>TV_VYN6A)2]'E-_,)XD]63]\W\0& ,W.LS@EFJRUEDHJ9-R3K66 M@W+T,9 ;7*R RDH8M7&$KP>IZ +#"VY91JJIE+)W@\WPH/20S=O%X8$U70T7 MTZ#\Z&(1@C"JAV>HA=7#B[.C&75TZ2 5 >0&N$6?K6#W>S"M&[" I;LD'CW! M/1A7JH?"C@>G5SC]_7(=9K &,\9_/ZBF5"ZJM\-2$5!^A%O\Z"!T;Y'G!,%# MW!L..!>*:Q>*"U3YB2\3)._VR,_Z)[KC'->K\U;&^E5BHU&-8E)X(8J3;O M[/OY[:++\MB27!0S^ZLU/%P!5(?*_:V-B-)W_O9&"CF>-']1K%GOOP%02P,$ M% @ IH*D4A%P,^7O" \5P !0 !H;&8M,C R,3 T,CA?;&%B+GAM M;,U<;6_;MA;^?H']!\[[<@?4<6P#&Q(T+G+3I B6)4&28?<%0R%+M"-<60PH MI7'^_4A)M$WRD*(K6A**-BK/;Q_ 9KX)AG&9YD(9X@!C^-"L:;T@8Y,6(=]S7 M$BS:GBE>P#P)I1L:'IT3'IWQ+SPZ/VV91TV&M^12>B)YD/@99\&GCU7K MIOF@;WV%UC;D6Y]19B6.6XCR3C?-!WV/:4RBRS0Z_,#5KGP-_C$/: M2T3MK M/H'#CQH8:L*;;MB5U"]>YSB-<"1ZYMR6>V?1=7&S+9@WW"246!.^BA"J3R=C MK 5CAL.C)?DVBG#,F,+O>7!DQQ1EYIB)4>M!%\3>;)7J&2,ET.S42Z2EBW_.$ I\,_ M'@KY_J]GHZIW&KIT)G%\5]DC4AWM;Q/@]* +$'3MGE M[: VFSS-LY,UG@_CCCZ1M]2VPNLH:'W?1?E:W;>B*7(: "A<0;_(N"0^C;8G; M3=@[+KJJ2V.?!*UD#%2S'F&;E$LTK.-=IK9$_)F$K_R19/-QPN<@5U5EQ523 M-6 :Z!AD]"5D&[E)R6:?F3"ATL9R'B%N[5;+]KP1QS#+:@;A0LX6KG9ORM=I M2.@+H<5G[H\Y&T557,#S[QX>TBV[QJ/Q'=S*[_>&[M*5_?Y>SR!N]Q+R RJP M_%E&W!F[?Q[?1Q#DNS(&+1!69WF]<.BG[7);$+HJAG/%+C"]P!EG M.:8XN@U6IKK;QU4I0#=7#Y7HTI'ODMRCS[K:=*;:%NG&Y0,JG5#AQ2MUZX>X M8S^*=2\5D6;9A>VRIH_J):!&7A-103"9T4K*II1V=YM'1@30^J#*>M910K-P@R=;+;O298'R7_C%^/C MG T(;;P5H*_MMT1[D$TXU(/35EQWU#;D)00Q3&^>RJQYA;;GQ@Q8-NF2#[A5 M!U@[*83BX>^.WE/R+4XU.;I H6+0H+[*02$^2$' ?3B5!.2J%<5FPR)@/2H+ M4XZAPK#DPE(:BA=8'"!S6^7QB,-7RL8RGLR?^#0429K,U91U

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end